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RÉSUMÉ 
Pendant des années, l’élévation de la température du corps, connu sous le nom d'hyperthermie, a 
été utilisée pour traiter les cellules cancéreuses. L'hyperthermie peut être atteinte via diverses 
méthodes invasives et non invasives, dont certaines sont pratiquées aux niveaux de la recherche 
clinique, et certaines autres ont déjà atteint l’approbation pour la pratique en clinique. Les 
nanoparticules magnétiques (NPM) peuvent générer de la chaleur et donc chauffer leur entourage 
une fois qu'ils sont placés dans un champ magnétique alternatif. Contrairement aux autres 
méthodes d’hyperthermie, l'hyperthermie par NPM utilisant un champ magnétique alternatif 
fournit un contrôle avancé et peut avoir un effet très localisé. En plus, les NPM ont un énorme 
potentiel pour les applications biomédicales d'imagerie, de diagnostic et de traitements. En plus, 
les NPM peuvent être propulsées par les gradients magnétiques vers un emplacement désiré du 
corps. La propulsion et le contrôle et l’hyperthermie permettent l'introduction d'un système 
robotique miniaturisé pour les applications thérapeutiques localisées. En effet, une fois chargé 
avec des agents thérapeutiques, les NPM peuvent être propulsées, ciblés vers l’organe malade et 
ensuite chauffés utilisant des champs magnétiques alternatifs qui induira une séquence 
d'actionnement des médicaments. Dans ce mémoire, les attributs physiques des NPM tel que 
l’aimantation, les domaines magnétiques, l’hystérésis, la relaxation et ainsi que divers 
mécanismes de chauffage sont étudiés. Aussi les limites biologiques qui permettent de déterminer 
la fréquence et l’intensité  des champs magnétiques alternatifs utilisés pour l’hyperthermie sont 
expliquées. 
Des NPM commercialement disponibles ont été utilisées pour étudier l'effet de la concentration 
sur l’élévation de température. Ainsi des échantillons de 1ml de magnétite en forme de fluide 
(ferrofluides) dont le diamètre des particules se situe entre 5 à 10 nm comprenant une couche de 
dextran ont été utilisés. Les tests sont réalisés avec des concentrations de 10, 25 et 50 mg/ml de 
ferrofluide. Les échantillons isolés avec polystyrène (Styrofoam) ont été chauffés par une bobine 
d'induction générant un champ magnétique alternatif d’environ 80 kA m-1 à 150 kHz. Après 900 
secondes, les échantillons ont montré 11,11°C, 27,78°C et 55,56°C d’élévation de température 
∆T respectivement. 
Pour examiner l’effet des couches enrobant les NPM sur l’élévation de la température, différents 
types d’enrobage a été expérimentés. Les différents enrobages sont l'amidon, l'acide oléique, 
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Polyacrylamide, Poly (acide maléique-co-oléfines), l'alcool de polyvinyle, SiMAG carboxyle, 
nanoparticules non couchés chargé anionique et cationique. Un échantillon de 0,5 ml de 25 
mg/ml de NPM avec chaque enrobage a été placé à l'intérieur d'un champ magnétique alternatif 
de 2 kA m-1 à 160 kHz pour 3000 secondes. Le débit d'absorption spécifique (SAR) estimé à 
partir du graphe de l’élévation de la température en fonction du temps et le SAR obtenu utilisant 
la courbe d'hystérésis ont été comparés. Les équations thermodynamiques ont été utilisées pour 
tracer la distribution de chaleur en fonction du temps et de la distance, les simulations obtenues 
sont en corrélation avec les résultats expérimentaux. Un échantillon de 1 ml de fluidMAG-PMO-
2 a été aussi placé à l'intérieur d'un bécher qui contenait de l'eau déminéralisée à 37ºC et été agité 
à 50 rpm. La température de l'échantillon atteint 42,44ºC lorsque un champ magnétique alternatif 
de 4,5 kA m-1 à 160 kHz est appliqué pour 1680 secondes. 
Enfin, les NPM encapsulés dans les hydrogels thermosensibles (NPM-PNIPA), servant comme 
mécanisme d'actionnement des médicaments par hyperthermie ont été testés. Les chaînes de 
polymère d’hydrogel expulsent leur contenu liquide quand ils atteignent la température critique 
(LCST) résultant dans la réduction du volume de ces derniers. Ici, 0,5 ml de NPM-PNIA avec 
une concentration de 5 et 10 mg magnétite /ml ont été placés dans un gel d'agar et aussi dans du 
Styrofoam et soumis à un champ magnétique alternatif de 9,2 kA m-1 à 145 kHz. Après 30 
minutes, une élévation maximum de 2,9°C pour la concentration de 5 mg magnétite/ml de NPM-
PNIA et 3,3°C pour la concentration de 10 mg magnétite/ml a été enregistrée dans le gel d'agar. 
Pour Styrofoam l’élévation maximum de température obtenue est de 2,1°C et 4,4°C pour les 
concentrations de 5 et 10 mg magnétite/ml, respectivement. Aussi un changement de volume 
remarquable dans NPM-PNIA ayant 10 mg magnétite/ml a été observé. Ensuite, près de 100 
NPM-PNIA sphères (diamètre d'environ 1mm) ont été placées dans un champ magnétique 
alternatif de 4 kA m-1 à 160 kHz. Après 1500 secondes, une élévation de 2°C a été observée.  
Dans ce mémoire, l’hyperthermie via l'induction du NPM a été étudiée. L'effet de la 
concentration des NPM et certains enrobages ont été évalués.  Des NPM-PNIA sphériques ont été 
aussi chauffées avec l'induction d'un champ magnétique alternatif. En raison de la présence des 
NPM, l’hydrogel NPM-PNIA peut être propulsé par le gradient d’un champ magnétique tel que 
celui d’un système d’Imagerie par Résonance Magnétique (IRM). Une fois que ces hydrogels 
contenant des agents thérapeutiques atteignent leur cible, un champ magnétique alternatif 
respectant les limites physiologiques tolérables est capable d’induire suffisamment de chaleur 
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pour réduire leur volume et donc actionner une séquence locale de libération du médicament. Il 
s'agit d'un pas de plus vers la libération ciblée d'agents thérapeutiques actionnée par 
l’hyperthermie induite par des champs magnétiques alternatifs. 
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ABSTRACT 
Elevation of body temperature, otherwise known as hyperthermia, has been used to treat 
cancerous cells for many decades. Hyperthermia can be achieved via various invasive and non-
invasive methods, some of which are being practiced at clinical levels, and some others have 
already reached clinical trials. Magnetic nanoparticles (MNP) can generate heat and thus heat 
their surroundings once they are placed in an alternating magnetic field (AC magnetic field). In 
contrast to other hyperthermia methods, hyperthermia via MNP in an AC magnetic field provides 
advanced control and can be highly localized. In addition, MNP have enormous potential in 
biomedical applications such as imaging, medical diagnosis and treatment. Also, agglomeration 
of MNP can be propelled with an inhomogeneous magnetic field towards a desired location. The 
propulsion, control and hyperthermia allow the introduction of a miniaturized robotic system. 
Indeed, MNP micro-carriers loaded with therapeutic agents can be propelled and tracked to a 
specific diseased organ and be heated upon exposure to the AC magnetic field and then begin 
hyperthermia and drug actuation sequence. In this thesis, the physical attributes of the MNP such 
as the magnetization, magnetic domains, hysteresis, and relaxations as well as various heating 
mechanisms are discussed. Also biological limits that determine the frequency and the intensity 
of AC magnetic fields used for hyperthermia are explained. 
Commercially available MNP were used to study the concentration effect of the MNP on the 
temperature. Thus, samples of 1ml of magnetite in the form of fluid (ferrofluids) whose particle 
diameter were between 5 to 10 nm with a layer of dextran coating were used. The tests were 
performed with concentrations of 10, 25 and 50 mg / ml of ferrofluid. The insulated samples by 
Styrofoam were heated by an induction coil generating an AC magnetic field near 80 kA m-1 at 
150 kHz. After 900 seconds, the samples showed 11.11°C, 27.78°C and 55.56°C temperature 
elevations respectively.  
To examine the effect of the coating of the MNP on the rise in temperature, various types of 
coating was tested. The coatings were Starch, Oleic acid, Polyacrylamide, Poly (maleic acid-co-
olefin), Polyvinyl alcohol, SiMAG Carboxyl, uncoated anionic and cationic charge magnetite 
nanoparticles. Therefore, 0.5 ml of 25 mg/ml of each coating was placed inside an AC magnetic 
field of 2 kA m-1 at 160 kHz for 3000 seconds. The SAR estimated from the graph of the 
temperature rise as function of time and the SAR obtained using the hysteresis curve were 
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compared. The thermodynamic simulations correlated closely with the experimental plots of the 
distribution of temperature as function of time and distance.  
A 1ml sample of fluidMAG-PMO-2 was placed inside of a beaker that contained deionised water 
at 37ºC and was stirred at 50 rpm. The sample temperature reached 42.44ºC when AC magnetic 
field of 4.5 kA m-1 at 160 kHz was applied for 1680 seconds.  
Finally, MNP encapsulated within thermo-sensitive hydrogels (MNP-PNIPA) serving as a 
mechanism of actuation of drug release by hyperthermia were tested. The hydrogel polymer 
chains collapse and expel the liquid content when they reach the critical solution temperature 
(LCST) resulting in the reduction of the volume of the latter. Here, 0.5 ml MNP-PNIPA samples 
with a concentration of 5 and 10 mg magnetite/ml were placed once in agar gel and once in an 
agar gel and also in the Styrofoam and subjected to an AC magnetic field of 9.2 kA m-1 to 145 
kHz. After 30 minutes, a maximum elevation of 2.9°C for the concentration of 5 mg 
magnetite/ml MNP-PNIPA and 3.3°C for a concentration of 10 mg magnetite/ml was recorded in 
the agar gel. The maximum temperature rise for Styrofoam was 2.1°C and 4.4°C respectively. 
Also remarkable change of volume in MNP-PNIPA of 10 mg magnetite/ml was observed. Then, 
nearly 100 MNP-PNIA spheres (about 1mm diameter) were placed in an alternating magnetic 
field of 4 kA m-1 to 160 kHz. After 1500 seconds, a rise of 2°C was observed. 
In this thesis, hyperthermia via induction of MNP has been studied. The effect of the 
concentration of MNP and some coatings were evaluated. The NPM-spherical PNIPA were also 
heated with the induction of an alternating magnetic field. Due to the presence of MNP, the 
MNP-PNIPA hydrogel can be propelled by the gradient of a magnetic field such as that of 
magnetic resonance imaging (MRI). Once these hydrogels containing therapeutic agents reach 
their target, an AC magnetic field within the tolerable physiological limits is able to induce 
sufficient heat to reduce their volume and thus activate a sequence of local drug release. This is a 
step closer to the targeted delivery of therapeutic agents activated by hyperthermia and induced 
by AC magnetic fields. 
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CONDENSÉ EN FRANÇAIS 
Chapitre 1 
Cancer 
Des cellules cancéreuses peuvent être produites en raison de facteurs externes comme le tabac, 
les produits chimiques, les radiations et les organismes infectieux ainsi que des facteurs internes, 
tels que les mutations héréditaires, les hormones, les facteurs immunitaires et les mutations qui se 
produisent dans le métabolisme. Lorsque les cellules cancéreuses sont produites sans retenue, une 
tumeur se forme. 
Hyperthermie 
L'hyperthermie est définie comme une élévation anormale de la température. En oncologie, 
l'hyperthermie se définie par l'échauffement d'organes ou de tissus à des températures entre 40°C 
et 45°C, à un point qui provoque l'inactivation cellulaire modérée et réversible. L'hyperthermie 
peut être considérée comme une thérapie complémentaire qui maximise l’effet des agents 
chimiothérapeutiques et de la radiothérapie. Les données disponibles suggèrent que 
l'hyperthermie modérée, inférieure à 42°C, augmente le flux sanguin vers la tumeur. Ce qui 
entraîne une meilleure oxygénation ainsi qu’une hausse de l’apport nutritif à la tumeur. Parmi les 
différentes applications de l'hyperthermie, l’actionnement est d'un grand intérêt lorsque 
l'hyperthermie localisée est utilisé pour déclencher un mécanisme de libération du médicament. 
Les Méthodes d’Hyperthermie 
1. L’hyperthermie de l’ensemble du corps: Dans cette méthode, tout le corps est chauffé, soit 
en empêchant le transfert de chaleur du corps vers le milieu environnant, ou en plaçant le 
patient dans un bain d'eau chauffée. 
2. L'hyperthermie par des applicateurs sans fil: 
a. Ultrasons focalisés de haute intensité (HIFU) 
Des ondes ultrasonores focalisées sont transmises à des tissus mous, ce qui cause des 
frictions moléculaires et de la chaleur mécanique. Les HIFU ne sont pas idéaux pour les 
zones situées près des os ou de l’air. 
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b. Applicateurs électromagnétiques (technique non invasive): 
i. Radiofréquence (RF): la technique de thermothérapie est basée sur le 
courant qui est induit par les ondes RF (0.5 - 300 MHz) dans un tissu 
biologique pour osciller les électrons libres et les ions. La chaleur est 
produite par la collision de ces électrons et ions avec des atomes 
immobiles. 
ii. L’antenne capacitive: la région d'intérêt du corps est placée entre deux 
plaques chargées. Un champ électrique induit entre ces plaques génère de 
la chaleur dans les tissus indépendamment de la profondeur de 
cible. Toutefois la graisse autour du tissu cible peut provoquer un 
échauffement superficiel excessif. 
iii. L’antenne inductive: La bobine d'induction crée des courants de Foucault 
dans le tissu et augmente la température. Cette chaleur est liée à la 
conductivité électrique du tissu. La variation de la conductivité des tissus 
peut provoquer une température non-uniforme. 
c. Micro-ondes: Basé sur le principe de chauffage diélectrique, les molécules d'eau 
absorbent l'énergie des micro-ondes. Étant donné que ces molécules contiennent des 
charges positives et négatives - les molécules d'eau sont bipolaires - elles essaient de 
s'aligner avec le champ électromagnétique des micro-ondes. Due à la haute fréquence, le 
mouvement moléculaire rapide provoque une élévation locale de la température. 
3. Insertion de source(s) de chaleur  (technique invasive): Des sources d’hyperthermie sont 
chirurgicalement placées à l'intérieur ou autour de la zone cible: 
a. Chauffage micro-ondes: ondes électromagnétiques d’antennes micro-ondes insérées à 
l'intérieur du tissu 
b. Chauffage par radiofréquences: l'insertion d'une paire ou d'un réseau d'électrodes RF 
macroscopiques à l'intérieur du tissu.  
c. Semences ferromagnétiques: des semences ferromagnétiques, aussi grandes que 
quelques centimètres, sont implantées et placées dans un champ magnétique oscillant. 
d. Nanoparticules: production de chaleur à partir de nanoparticules. 
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Chapitre 2 
Les deux composantes du champ électromagnétique, plus précisément, le champ électrique ainsi 
que la variation du champ magnétique, sont responsables de la production de chaleur dans un 
tissu. Les effets thermiques sont déterminés par les propriétés diélectriques du tissu et les 
propriétés magnétiques du milieu. Étant donné que les matières biologiques n'ont pas 
d'importantes propriétés magnétiques, les nanoparticules magnétiques, ou NPM, biocompatibles 
sont utilisées pour augmenter l'influence de la variation du champ magnétique. Dans ce projet, 
l'accent est mis sur la composante magnétique d’un champ électromagnétique de basse fréquence. 
Les nanoparticules magnétiques en hyperthermie 
Les NPM composée de métaux comme le fer, le cobalt et le nickel et leurs alliages sont utiles en 
raison de leurs propriétés magnétiques et multifonctionnelles. Ces nanoparticules sont capables 
de créer de la chaleur une fois placées dans un champ magnétique alternatif externe. Parmi les 
compositions chimiques différentes des NPM, l’oxyde de fer a été le plus utilisé pour 
l'hyperthermie. Cela est dû à sa biocompatibilité, sa biodégradabilité et sa faible toxicité. 
Génération de chaleur des NPM utilisant un champ magnétique alternatif 
La chaleur générée par les NPM soumises à un champ magnétique alternatif (champ magnétique 
AC) est principalement causée par les trois mécanismes suivants: perte par hystérésis, relaxation 
brownien et de Néel. 
Les domaines magnétiques contiennent un grand nombre de moments magnétiques 
atomiques. En l'absence d'un champ magnétique externe,  les moments magnétiques sont alignés 
le long des axes cristallographiques magnétiques appelés « axes faciles ». L'énergie nécessaire 
pour faire pivoter les domaines magnétiques avec un champ magnétique externe est appelée 
anisotropie de l'énergie E = KV, où K est la constante d'anisotropie effective et V est le volume 
du noyau magnétique. 
Les matériaux ferromagnétiques qui se composent de plusieurs domaines magnétiques sont 
appelés matériaux multi-domaines. Lorsque ces matériaux sont soumis à une augmentation et une 
diminution du champ magnétique externe H, la courbe d'aimantation ne coïncide pas. Par 
conséquent, le matériel démontre «un comportement d'hystérésis» et des pertes par hystérésis se 
manifestent  par transfert de chaleur vers le milieu environnant. Mathématiquement, le taux 
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d'absorption spécifique (SAR) est proportionnel au produit de la fréquence par l’intégrale fermée 
de la boucle d'hystérésis. En d'autres termes, plus la zone à l'intérieur de la boucle est grande, 
plus il y a de chaleur dissipée dans la région environnante. Toutefois, pour bénéficier de la 
génération de chaleur d’une boucle d'hystérésis complète, les particules doivent être saturées avec 
des champs magnétiques élevés de l'ordre de quelques milliers d'Oersted, ce qui ne convient pas 
pour le corps humain. 
Une fois soumis à un champ magnétique externe alternatif, le matériau magnétique présente un 
cycle d'hystérésis étroit. L'orientation des moments magnétiques de ces particules, appelées 
particules superparamagnétiques, change continuellement, ce qui empêche les pertes  par 
hystérésis  de se produire. Dans un champ magnétique alternatif de haute amplitude, l'énergie 
peut permettre aux moments magnétiques de s’aligner le long de la direction du champ externe en 
surmontant la barrière d'énergie thermique. Cependant, une fois que le champ magnétique externe 
est enlevé, les moments magnétiques prennent un certain temps à perdre cet alignement. Ceci est 
connu comme le mécanisme  de relaxation de Néel qui peut également provoquer une libération 
d'énergie sous forme de chaleur. 
Le troisième mécanisme de chauffage est la relaxation brownienne qui survient à la fois sur les 
multi-domaines et les particules n’ayant qu’un seul domaine. Le temps de relaxation brownien, 
τB, est défini comme le temps que prend la particule à tourner sous l’influence du champ 
magnétique externe, de la viscosité du milieu, ainsi que du volume hydrodynamique des 
particules. 
Débit d'absorption spécifique (SAR) 
Le SAR (W g-1) est proportionnel au taux de variation de la température du matériau magnétique 
et il est donné par la formule suivante: 
   	



    
où c est la capacité thermique spécifique de l'échantillon (4.185 J l-1 K-1 pour l'eau), m est la 
masse des particules magnétiques,  représente le volume de l'échantillon et   exprimée en °Ks-
1
 est la variation de température qui est obtenue de façon expérimentale. 
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Dissipation thermique 
En théorie, l’énergie provenant des particules magnétiques uniformément distribuées à l'intérieur 
d'une tumeur sphérique de rayon R soumis à un champ magnétique alternatif dissipera la chaleur 
aux tissus environnants tant que la température n’atteindra pas l'état d'équilibre. La figure 1, dans 
laquelle r représente la distance entre le centre du volume sphérique  et un point à l'infini, illustre 
ce concept. 
 
Figure 1. La température en fonction de la distance 
Les  équations thermodynamiques de transfert de chaleur en fonction du temps (figure 2) aident à 
optimiser et prédire le temps d'exposition nécessaire afin d’élever la température des tissus 
jusqu'à une température cible respectant les limites physiologiques.  
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Figure 2. Simulation MATLAB® pour augmentation de la température en fonction de la distance 
(Appendis A.3) 
Les propriétés magnétiques adaptées à l'hyperthermie 
Les propriétés magnétiques adaptées à l'hyperthermie ne sont pas seulement régies par les 
paramètres magnétiques des NPM, mais aussi par les limites physiologiques qui sont conçues 
pour protéger les organismes vivants contre les champs magnétiques élevés. Ces paramètres sont 
la taille, la concentration des NPM, les limites maximales de l'amplitude et de la fréquence du 
champ magnétique alternatif. 
Hydrogel 
Le PPNIPA est un hydrogel qui  réduit sa taille lorsqu'il est chauffé et se gonfle lorsqu’il est 
refroidi. Ce mécanisme discontinu et réversible se produit à une température de transition appelée 
LCST (Lower Critical Solution Temperature). Aux températures inférieures au LCST, les 
liaisons hydrogènes entre les groupes hydrophiles de la chaîne polymère sont dominantes. 
Lorsque la température est élevée au dessus du LCST, les liaisons hydrogènes deviennent faibles 
et les liaisons hydrophobes deviennent plus fortes. Ainsi l'eau est expulsée hors de l'hydrogel. Ce 
phénomène entraîne un changement de couleur (l’hydrogel devient opaque) et un changement de 
volume. Le LCST du  PPNIPA est autour de 32 ° C, et peut être augmenté au-dessus de la 
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température corporelle. Dans notre cas, le LCST pour le PPNIPA contenant des NPM a été 
déterminé à 29 ° C (figure 3). 
 
Figure 3. Des NPM incorporées dans l’hydrogel PNIPA  
 
NPM et le gradient de champ magnétique 
Le gradient de champ magnétique de l'IRM permet d'orienter l'agglomération des NPM. La force 
créée à l’intérieur de l'IRM peut être calculée à partir de l’équation suivante : 
  .   
Dans l’équation ci-dessus,  est la force magnétique (N),  est l'aimantation du matériau (A m-
1), V est le volume du matériau magnétique (m3),  est l'induction magnétique (T) et ∇B est le 
gradient (variation spatiale) de l'induction magnétique (T m-1). 
Chapitre 3 
Effet de la concentration sur la génération de chaleur 
Des NPM commercialement disponibles ont été utilisées pour étudier l'effet de la concentration 
sur l’élévation de température. Ainsi des échantillons de 1ml de nanoparticules de magnétite en 
dispersion (ferrofluides), dont le diamètre se situe entre 5 et 10 nm et recouvertes d’une couche 
de dextran, ont été utilisés. Les tests sont réalisés avec des concentrations de 10, 25 et 50 mg/ml 
de ferrofluide. Les échantillons isolés avec du polystyrène (Styrofoam) ont été chauffés par une 
bobine d'induction générant un champ magnétique alternatif d’environ 80 kA m-1 à 150 
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kHz. Après 900 secondes, les échantillons ont montré 11.11°C, 27.78°C et 55.56°C d’élévation 
de température ∆T respectivement. 
 
Figure 4. Élévation de la température en fonction de temps  
Effet du revêtement des MNP sur la génération de chaleur 
Différents types de couches recouvrant les NPM ont été expérimentés, pour examiner leur effet 
sur l’élévation de la température. Les différents enrobages sont l'amidon, l'acide oléique, le 
polyacrylamide, le poly (acide maléique-co-oléfines), l'alcool de polyvinyle, SiMAG carboxyle, 
ainsi que des nanoparticules non enrobées chargées positivement et négativement. Un échantillon 
de 0,5 ml de NPM à 25 mg/ml avec chaque enrobage a été placé à l'intérieur d'un champ 
magnétique alternatif de 2 kA m-1 à 160 kHz pour 3000 secondes (Figure 5). Le SAR estimé à 
partir du graphe de l’élévation de la température en fonction du temps et le SAR obtenu utilisant 
la courbe d'hystérésis ont été comparés. Les équations thermodynamiques ont été utilisées pour 
tracer la distribution de chaleur en fonction du temps et de la distance. Les simulations obtenues 
sont en corrélation avec les résultats expérimentaux.  
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Figure 5. Effet de l’enrobage des NPM sur l’hyperthermie 
Un échantillon de 1 ml de fluidMAG-PMO-2 a été aussi placé à l'intérieur d'un bécher qui 
contenait de l'eau déminéralisée à 37ºC et a été agité à 50 rpm. La température de l'échantillon a 
atteint 42,44ºC lorsque un champ magnétique alternatif de 4,5 kA m-1 à 160 kHz a été appliqué 
pour 1680 secondes. 
 
NPM encapsulées dans l’hydrogel 
Enfin, les NPM encapsulées dans les hydrogels thermosensibles (NPM-PPNIPA), servant comme 
mécanisme d'actionnement de la libération des médicaments par hyperthermie ont été testées. Les 
chaînes de polymère d’hydrogel expulsent leur contenu liquide quand ils atteignent la 
température critique (LCST), menant à la réduction du volume de l’hydrogel. Ici, des échantillons 
de 0,5 ml de NPM-PPNIPA avec des concentrations de 5 et de 10 mg de magnétite  par ml ont 
été placés dans un gel d'agar  et ont été soumis à un champ magnétique alternatif de 9,2 kA m-1 à 
145 kHz. Après 30 minutes, une élévation maximale de 2,9°C a été enregistrée pour la 
concentration de 5 mg magnétite/ml de NPM-PNIA et de 3,3°C pour la concentration de 10 mg 
magnétite/ml. Les mêmes tests ont été effectués, mais en plaçant les échantillons  dans du 
Styrofoam plutôt que l’agar, et les élévations maximales de température obtenues  ont été de 
2,1°C et 4,4°C pour les concentrations de 5 et 10 mg magnétite/ml, respectivement.  
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Un changement de volume remarquable de l’échantillon de NPM-PPNIPA ayant 10 mg de 
magnétite par ml a également été observé (Figure 6). 
 
Figure 5. 60% changement de volume des hydrogels (a-d) @ 29°C 
Par la suite, près de 100 sphères de NPM-PPNIPA (diamètre d'environ 1mm) ont été placées dans 
un champ magnétique alternatif de 4 kA m-1 à 160 kHz. Après 1500 secondes, une élévation de 
2°C a été observée (Figure 6).  
 
Figure 6. Élévation de température pour 100 NMP-PNIPA 
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Discussion et Conclusion 
La motivation derrière le travail présenté dans ce mémoire était de réaliser un procédé 
d'activation pour un système robotique miniaturisé. De tels robots, aussi connus comme micro-
carrier, se propulsent dans le réseau vasculaire d'un tissu cible comme une tumeur et 
l’augmentation de la température produite par hyperthermie actionne une séquence de libération 
du médicament. Dans la miniaturisation des robots navigables dans le corps humain, il est très 
important de réduire le nombre de composants. Cette réduction peut être obtenue en augmentant 
la fonctionnalité de chaque composant à son maximum. Un micro-carrier dans le corps humain a 
besoin de propulsion, de suivi et d'activation. Comme le montre la figure 7, les NPM peuvent 
contribuer à ces trois critères. 
 
Figure 7. NPM comme actionneur hyperthermique navigables et détectables 
Le SAR atteint une valeur maximale de 61,02 W g-1 pour les nanoparticules de magnétite de 20 
nm enrobées avec du poly (acide maléique-co-oléfines) et soumises à des champs magnétiques 
alternatifs de 4,5 m KA-1 à 160 kHz. Ces nanoparticules peuvent être intégrées dans des micro-
dispositifs de 50 µm de diamètre, contenant un médicament,  et pouvant être immobilisés dans un 
volume cible de 30 mm de diamètre par embolisation. Pour propulser les transporteurs par le 
biais de capillaires utilisant les gradients de l'IRM, une agglomération des nanoparticules de 
magnétite occuperont environ 40% du volume du  micro-carrier. L'eau, les chaînes de polymère 
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d’hydrogel et les agents thérapeutiques comptent pour les 60% restants de volume. La figure 8 
montre cette situation hypothétique. 
 
Figure 8. Embolisation de micro-carrier dans la zone cible 
Une simulation par ordinateur prédit qu’après 700 secondes, la température au centre de la zone 
cible qui contient 110,000 micro-carriers serait élevée de 3 degrés. Une telle élévation est 
suffisante pour l’activation d’une séquence de libération d’agents thérapeutiques contenus dans 
les micro-carriers. 800 secondes après, l'élévation de la température serait d’environ 5 degrés, ce 
qui est suffisant pour l'hyperthermie modérée de la zone cible. Une présentation graphique de 
cette simulation est illustrée à la figure 9. Comme on le voit dans cette figure, l'élévation de la 
température décroît rapidement à mesure qu’on s’éloigne du centre de la zone ciblée. Cela 
signifie que pour une application d’hyperthermie, l’augmentation de la température peut être 
tenue loin des tissus sains avoisinants. 
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Figure 9. MATLAB® simulation, la température augmente en fonction du temps d’exposition aux 
champs magnétiques alternatifs pour une distance donnée. 
Dans ce mémoire, l’hyperthermie via l'induction des NPM a été étudiée. Les effets de la 
concentration des NPM et de certains traitements de surface ont été évalués.  Des NPM-PPNIPA 
sphériques ont aussi été chauffées avec l'induction d'un champ magnétique alternatif. En raison 
de la présence des NPM, l’hydrogel NPM-PPNIPA peut être propulsé par le gradient d’un champ 
magnétique tel que celui d’un système d’Imagerie par Résonance Magnétique (IRM). Une fois 
que ces hydrogels contenant des agents thérapeutiques atteignent leur cible, un champ 
magnétique alternatif respectant les limites physiologiques tolérables peut induire suffisamment 
de chaleur pour réduire leur volume et donc actionner une séquence locale de libération du 
médicament. Il s'agit d'un pas de plus vers la libération ciblée d'agents thérapeutiques actionnée 
par l’hyperthermie induite par des champs magnétiques alternatifs. 
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1 
INTRODUCTION 
Elevation of body temperature, otherwise known as hyperthermia, has been used to treat 
cancerous cells for many decades. Hyperthermia can be achieved via various invasive and non-
invasive methods, some of which are being practiced at clinical levels, and some others have 
already reached clinical trials. Magnetic nanoparticles (MNP) can generate heat and thus heat 
their surroundings once they are placed in an alternating magnetic field (AC magnetic field). In 
contrast to other hyperthermia methods, hyperthermia via MNP in an AC magnetic field provides 
advanced control and can be highly localized. In addition, MNP have enormous potential in 
biomedical applications such as imaging, medical diagnosis and treatment. Also, agglomeration 
of MNP can be propelled with the magnetic force from the gradient of a magnetic field towards a 
desired target location. The multi-functionality nature of MNP and their controllable physical 
parameters are the motives behind miniaturized robotic systems for tracking, propulsion and 
actuation of therapeutic agents inside human body.  
This evaluation starts with a brief introduction to cancer and hyperthermia and follows by a short 
summary of key methods of hyperthermia as well as advantages of MNP and AC magnetic field. 
These advantages are not limited to tracking, propulsion and hyperthermia. For instance, the 
colloidal ability of MNP can alter the biological environment of the target tissue and initiate an 
immunological reaction. In later chapters, physical attributes of MNP, magnetic field and various 
heating mechanisms are introduced. Also biological and industrial limitations that lead to a set of 
magnetic parameters for MNP hyperthermia are explained. Thermo sensitive gels called 
hydrogels are introduced as potential carriers for the next generation of targeted drug delivery. 
These carriers are able to shrink and release their contained liquid with therapeutic agents upon 
elevation of temperature. Such elevation of temperature can be obtained from hyperthermia of the 
encapsulated MNP within the hydrogels by an AC magnetic field. The force that would propel 
these carriers in the vascular network to a target tissue is the gradient force of the magnetic field 
of a Magnetic Resonance Imaging (MRI) that applies on the agglomeration of MNP within the 
hydrogels. These MNP within the carriers can be seen as distortion of the images of the MRI and 
therefore can be tracked at the same time. Therefore, evaluation of hyperthermia to fit into 
realization of a systematic traceable and navigable hyperthermic drug release mechanism is a 
prerequisite.   
2 
CHAPTER 1 LITERATURE REVIEW 
1.1 Cancer 
Cells are the smallest living structural and functional units of the body. They have the ability to 
divide, synthesize protein, respond to extra cellular changes such as temperature and pH etc. 
Among all cell functionalities, DNA replication is one of the most important one. Errors in DNA 
replication are a major cause of damage to cells. In this sense, cells must produce exact copies of 
themselves in order to remain healthy. To do so, they must ensure that DNA replication is done 
correctly during each cell division cycle. One of many processes that ensure the divided cells are 
as healthy as the mother cell is called the cell cycle checkpoint process. It is a control system that 
checks the output of cell division step by step at several checkpoints. At any step, if the result is 
not satisfactory, the system prevents the parent cell from dividing any further. One of the 
important functions of the checkpoints is to check for any DNA damage. Once damage is found, 
the checkpoint uses another mechanism to pause any cell activity until the damage is repaired. In 
case the damage is un-repairable, the cell is sent to be destroyed or to commit suicide via 
apoptosis [1]. Despite the security checks, as a result of external factors such as tobacco, 
chemicals, radiation and infectious organisms as well as internal factors such as inherited 
mutations, hormones, immune conditions and mutations that occur from metabolism, damaged 
cells may still be produced [2] .While healthy cells duplicate exact copies of themselves, and stop 
reproducing when necessary, and stay together and self destruct when they are damaged beyond 
repair, unhealthy cells do not follow the same pattern. In some cases DNA error cannot be 
repaired or stays hidden and therefore the cell does not know when to stop reproducing or self-
destruct. Sometimes these cells are produced far more than they can be terminated. These 
unhealthy cells could eventually lead to development of cancer cells. When cancer cells are 
produced unrestrained, a tumour is formed. Since these cells can travel in the body freely, they 
become more fatal once they rest in vulnerable organ such as soft heart tissue or bones. 
According to American Cancer Society there are more than 15 cancerous sites in the human 
body. These sites include oral cavity and pharynx, digestive system, respiratory system, bones 
and joints, soft tissue (including heart), skin, breast, genital system, urinary system, eye and orbit, 
brain and other nervous system, endocrine system, lymphoma, multiple myeloma and leukemia. 
Statistics from the Canadian Cancer Society suggests an estimated 171,000 new cases of cancer 
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in 2009 from which 75,300 patients will lose their lives. American Cancer Society predicts even 
more devastating numbers: in the year 2009 cancer is expected to take 562,340 American lives, 
more than 1500 Americans per day [3]. As cancer remains one of the leading death causes in 
North America, researchers around the world try to find more suitable treatments to battle this 
deadly disease. 
1.2  Hyperthermia 
Since the late 1960s, the concept of hyperthermia has drawn a lot of attention to the field of 
medicine. Hyperthermia is defined as an abnormal elevation of temperature. Unlike fever, which 
is regulated by the body’s temperature set-point, hyperthermia can be created artificially by 
means of drugs or medical devices. Because of its cytotoxicity effect, it is sometimes used as a 
rehabilitation method and therefore named thermal (heat) therapy or thermotherapy. 
Hyperthermia can reduce arthritis pain, relieve muscle spasms, reduce inflammation, and increase 
blood flow to provide nutritious needs to injured tissue [4]. It is well-known that sustained 
elevation of temperature due to hyperthermia above 42°C – 43°C causes necrosis of living cells 
[5]. Clinical trials since the 1970s have led to the hypothesis that “the cytotoxicity effect of 
hyperthermia is mainly based on denaturation of cytoplasmic and membrane proteins”. Cellular 
death rate due to heat exposure varies depending on the sustained temperature and the duration of 
hyperthermia. This rate is also dependent on the phase of the cell cycle, i.e. Mitosis, G1, DNA 
synthesis (S-phase), and G2 which explains the different mechanisms of cell deaths [6]. 
In oncology, hyperthermia refers to the heating of organs or tissues in various ways, to 
temperatures between 40°C and 45°C, at which point it causes moderate and reversible cellular 
inactivation. This heat can lead to preferential death of malignant cells by enhancing cell 
sensitivity and vulnerability towards more established forms of cancer therapy such as radiation 
[7, 8] and chemotherapy (thermal chemosensitization, thermal radiosensitization) [6, 9]. 
Hyperthermia leads to a synergistic effect in anti-cancer techniques such as chemotherapy. More 
specifically, hyperthermia can be seen as a complementary therapy that yields maximum benefit 
from chemotherapeutic agents such as alkylating agents, platinum compounds or threshold 
behaviour (anti-neoplastic) agents such as doxorubicin, and independent or additive agents such 
as fluorouracil, taxanes, and vinca alkaloids, while minimizing their applied dosage to the 
physiological system and thus reducing their toxic side effects that harm healthy cells [10]. 
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Hyperthermia, as used in cancer treatment, is meant to target unhealthy cells and keep the healthy 
cells unharmed. Healthy cells have organized and systematic blood flow in their surrounding 
vascular network, and via such they can easily cool down and dissipate excessive heat by means 
of conduction and convection. Cancer cells on the other hand have often far less developed 
vascular network and therefore overheat [11]. Studies show that at temperatures above 42°C 
tumour blood flow decreases [6]. Here, changes such as viscosity of blood cell membrane lead to 
hypoxia, acidosis, and cell energy deprivation. Available data suggests that moderate 
hyperthermia below 42°C increases tumour blood flow which leads to higher supply of oxygen 
and nutritious supplements to the tumour. The resultant increase in blood flow assists in efficient 
delivery of drugs and chemotherapeutic agents to the tumour, and increased oxygen supply 
favours radiotherapy effects. 
Hyperthermia also has other advantages that lead to cancerous cell death. Due to the elevation of 
cell temperatures during hyperthermia, cells undergo a series of morphological changes to their 
membranes, cytoskeletons, cellular proteins and nucleic acids [6]. Also, pre-clinical studies 
suggest that, similar to fever, hyperthermia is associated with immunological reactions and can 
stimulate and activate host immune systems against malignant cells [12]. Hyperthermia also 
seems to overcome drug resistance above moderate temperatures. The cytotoxicity of certain anti-
neoplastic drugs such as doxorubicin is reported to be substantially enhanced above specific 
temperatures [13].  
Among different applications of hyperthermia, ‘actuation’ is of high interest. Here, localized 
hyperthermia is used to trigger a drug release mechanism. For instance, therapeutic agents 
encapsulated in special thermo-sensitive hydrophilic polymers such as PNIPA [11, 14]  are able 
to reduce in volume up to thousands of times when heated [15], therefore releasing the drugs 
contained within. This is discussed in more detail in the following chapters. 
1.2.1 Methods of Hyperthermia 
There is a wide spectrum of hyperthermia methods but it can be generally classified into three 
groups: whole body hyperthermia, hyperthermia by wireless applicators, and hyperthermia by 
insertion of heating source(s). Here, each approach is briefly discussed. 
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I. Whole body hyperthermia – This complementary technique to cytotoxic drugs and/or 
radiotherapy is one of the oldest among all other types of hyperthermia. In this method, the 
entire body is heated either by preventing body heat transfer to the surrounding medium, or 
placing the patient inside a bath of heated water operated by specialist in a controlled 
environment. As seen in Figure 1.1, the head of the patient is usually placed outside of the 
heating chamber to avoid further complications, and the rest of the body is heated inside the 
chamber. Whole body hyperthermia is commercially available, and due to its simplicity is 
usually recommended for patients at high risk of relapse after surgical removal of a tumour 
[16]. 
 
Figure  1.1. Whole body hyperthermia  
Whole body hyperthermia lacks homogeneity of heat distribution in the tissue and may cause 
superficial overheating, thermal lesions, and discomfort caused by surface burning. Recently, 
a computerized perfusion method was suggested to solve this issue [17]. Nevertheless, 
sustained elevated body temperature may have a negative impact on healthy organs, such as 
the heart, which can result in cardiac disorders, and may cause changes in thrombocytopenia 
and the intravascular coagulation system.  Other side effects may be a decrease in volume of 
blood plasma (hypovolaemia) and capillary leak syndrome [10].Therefore, pursuit of a 
localized hyperthermia method is still of high interest.  
 
II. Wireless applicators (noninvasive): These methods can be considered regional or local 
hyperthermia methods. They consist of sending waves to the target area where, depending on 
the physical properties of the tissue and the applicator(s), the energy of the wave is 
transformed into heat. Such applicators are the subject of many clinical studies and are 
commercially available. Below, three major wireless applicators are mentioned. 
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a. High Intensity Focused Ultrasound (HIFU) 
Ultrasound is a sound pressure wave that has frequencies higher than what humans are able to 
hear. It is used for imaging of soft tissue by penetrating ultrasonic waves inside the tissue and 
measuring the reflected signature. Ultrasound is a fairly simple, safe, highly controllable, cost 
effective and widely available technology. Once ultrasonic waves are focused and transmitted to 
the soft tissue, molecular friction causes mechanical heat. High Intensity Focused Ultrasound 
(HIFU) can further heat the tissue leading to thermo-ablation. In thermo-ablation the target 
temperature is high enough to burn and instantly destroy cells.  Figure 1.2 illustrates a schematic 
and Magnetic Resonance Imaging (MRI) image of a uterine fibroid being treated by emitting 
ultrasound waves through a transducer. As seen in this figure, the waves are focused by a lens 
and beamed directly on the target tissue. 
 
Figure  1.2. High Intensity Focused Ultrasound [18] 
Despite impressive and promising results from recent clinical studies by InSightec© [19] 
HIFU may not be ideal for areas near bones or gas. Sound waves travel at different speeds 
depending on the reflection index of the medium. Sound waves are partially reflected 
rather than transmitted at the interface of air and tissue or tissue and bone, due to sudden 
change of reflection indices. At such interfaces the wave energy is absorbed elsewhere 
causing hot spots. Therefore HIFU would not be best for lungs and near bones. Also due 
to occasional non-uniform heat distribution, hot spots are common results of the treatment 
which cause discomfort for the patient [20]. 
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b. Electromagnetic applicators (non-invasive): 
 
1. Radiofrequency (RF) – This widely and commercially available thermotherapy 
technique is based on current that is induced by RF waves (0.5 – 300 MHz) in a 
biological tissue to oscillate free electrons and ions. Heat generation is due to collision 
of such electrons and ions with immobilized atoms. Elevation of temperature depends 
on the position and the geometry of the RF antenna as well as its frequency and power. 
There are two approaches for RF antennas: capacitive plates and inductive coils [21]. 
 
- Capacitive antenna: the region of interest of the body is placed between two charged 
plates. Electric field induced between these plates generates heat in the tissue 
regardless of target depth. However fat around the target tissue may cause excessive 
superficial heating. When the target area is deeper in the body, homogeneity and 
uniformity of heat distribution decreases rapidly. Figure 1.3 shows this type of RF 
applicator.  
 
 
Figure  1.3. Capacitive Applicator 
- Inductive antenna: this type of regional thermotherapy consists of an induction coil 
that creates eddy current in the tissue causing it to heat. This heat is related to 
electrical conductivity of the tissue. Thus variation in tissue conductivity may cause 
non-uniform temperature distribution, as some parts of the tissue may heat up more 
than others. 
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To solve inhomogeneous temperature distribution issues related to RF, researchers have 
introduced multiple and resonant cavity antennas [22, 23]. However more work is needed 
both theoretically and experimentally to overcome these issues.  
 
2. Microwave – In the electromagnetic spectrum, microwaves are waves having frequencies 
between 300 MHz and 30 GHz (infrared frequencies). In a process called dielectric 
heating, water molecules within the biological entity absorb microwave energy. Since 
these molecules contain positive and negative charges – water molecules are bipolar – 
they try to align themselves with the electromagnetic field of the microwave. Due to high 
frequency, this leads to fast molecular motion and causes local elevation of target 
temperature. Microwave has a better convection profile than RF and therefore more 
efficient temperature distribution [24]. It is evident that apart from heat, the electrical field 
of the microwave leads to changes in secondary and tertiary structure of microorganisms 
which contributes further in cell death [25]. Clinical trials for noninvasive localized 
hyperthermia are considered with microwaves at 433 MHz [26], 915 MHz, and 2450 
MHz [27]. Normally, microwave induced hyperthermia is best for superficial tumours 
because microwave cannot penetrate to target tissues deeper than few centimetres under 
the skin [28]. This is due to the high absorptive nature of water and its dense availability 
in human tissue. This is a disadvantage because it may cause uneven heat distribution and 
power absorption in and around deep seated target tissues. Researchers have partially 
addressed this issue by proposing the use of in phase multiple array antennas which allow 
for deeper penetration [29]. In this case, target volume, desired temperature and target 
depth determine the number of antennas, frequencies and power. To name a few 
approaches, researchers have used rotating spiral and multi loop antennas in many pre-
clinical studies but these techniques still lack temperature homogeneity at deep seated 
target tissue [26, 30]. 
 
III. Insertion of heating source(s) (invasive): In this type of thermotherapy heating sources are 
surgically placed inside or around target area. This method was first presented in 1975 as 
‘invasive interstitial technique for delivery of hyperthermia’ [31]. Due to the invasive nature 
of this technique, it can cause discomfort and complications prior to, during and after each 
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treatment. Also, slight movement of the implants as a result of any movement of the patient 
may affect the treatment measurements. This method can be performed via one of the 
following techniques: 
 
a. Microwave heating: Electromagnetic waves from inserted microwave antennas or coaxial 
waveguides agitate polar molecules of water and cause them to heat [24]. This method 
was developed to minimize heterogeneity of microwave heat distribution in the tissue 
while further localizing microwave thermal therapy.  
 
b. Radiofrequency heating: Insertion of a pair or an array of macroscopic RF electrodes 
inside the tissue to convert electromagnetic energy from RF waves to heat [21]. A down 
side to this is that after some time current that runs through these electrodes causes a 
charring effect. This effect leads to the formation of an insulator around the electrode that 
will interfere with desired wave emission [32]. Also there have been reports of local 
burning around the electrode due to excessive evaporation of water at this zone [24].  
 
c. Ferromagnetic seeds: In this method implanted ferromagnetic seeds as large as a few 
centimetres – also known as thermoseeds – are placed inside an oscillating magnetic 
induction field. Thermoseeds absorb the field energy and induce eddy currents. Heat is 
then generated by the eddy current losses leading to interstitial hyperthermia. This heat is 
then transferred to the surrounding tissue by thermal conduction without the need for 
electrical connection between implanted seeds and a power source [33]. 
 
IV. Nanoparticles: Generation of heat from these particles, unlike thermoseeds, is not limited to 
eddy currents. Heat may also be generated due to hysteresis loss, relaxation losses, or other 
types of losses due to infrared or microwave energy absorption. In this method, nanoparticles 
have to be injected in the tissue at which thermal therapy is desired. That is why some may 
classify it as an invasive hyperthermia technique. In the following section, this approach is 
discussed in more detail. 
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1.3 Advantages of Nanoparticles 
Various methods to synthesize nanoparticles provide scientists the ability to selectively control 
the core size of nanoparticles [34]. This ability allows researchers to use nanoparticles to target a 
wide range of biological entities, such as cells (10-100 µm), viruses (20-450 nm), proteins (5-50 
nm) and genes (2 nm wide, 10-100 nm long) [35]. In addition, targeting biological entities has 
been achieved using the colloidal ability of nanoparticles and dispersion by means of specific 
antibody coatings, such as dextran, polyvinyl alcohol and phospholipids [35].  Such coatings also 
serve as a protective shell to minimize direct exposure of the nanoparticle core to the biological 
environment. For cancerous cells, once the nanoparticles are located within the cell via 
intracellular, interstitial or membrane bonding, experiments show that even after mitosis, 50% of 
the particles remain within the tumour cells [36]. This is advantageous, should repeated 
hyperthermia treatment become necessary. Other studies show that cells react to the topography 
cues of their environment and neighbouring cells. Nanoparticles attached to the cancer cells 
influence the shape of the cell cytoskeleton formation. These cells present nano-bumps and nano-
spheres to the neighbouring cells encouraging them to switch from growth to apoptosis – cell’s 
self destruction mechanism [37]. 
Magnetic nanoparticles (MNP) can be excited once placed in an alternating magnetic field (AC 
magnetic field), regardless of their depth inside biological tissue. On the contrary, other 
techniques such as RF, Microwave and HIFU, are not able to accurately target cancerous tissue. 
This is due to increasingly complex parameters as penetration depth increases [38]. On the other 
hand, homogenous cell temperature increase may be achieved without the formation of ‘hot 
spots’ if sufficient concentration of MNP with proper coatings and colloidal ability are used [36]. 
MNP experience a thrust force when exposed to a magnetic gradient field, therefore an 
agglomerated ensemble of MNP can be propelled through the circulatory system to a desired 
target area. Such gradient force can be obtained from a clinical MRI [39] where functionalized 
MNP are seen in real-time as distortions of the magnetic field during imaging sequence. MNP 
can be used as MRI contrast agents, a property that allows for confirmation of their distribution 
to the target area prior to any treatment [38].  
A systematic hyperthermic drug release actuation can be obtained by encapsulating MNP in 
thermo-sensitive hydrogels along with therapeutic agents. Biocompatible temperature sensitive 
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gels are able to shrink up to thousand times in response to small temperature increase [11]. While 
acting like a sponge, these hydrogels may assist release of therapeutic agents embedded within 
the gel at an adjustable desired temperature. In a therapeutic setting, MNP can be used to heat the 
hydrogel once it is propelled to the desired location thereby releasing therapeutic agents at the 
target site only.  
Last but not least, MNP can be engineered to have relatively low Curie temperature points which 
leads to self regulation and thus avoids overheating the tissue when excited by an AC magnetic 
field [40]. For instance, Ag-doped manganite nanoparticles have shown great self regulating 
properties and have a curie temperature range of 41 – 44ºC [41]. In this sense, use of invasive 
temperature measurements such as fibre optics probes becomes unnecessary and instead non-
invasive methods such as MRI temperature mapping become more practical [42]. 
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CHAPTER 2 THEORETICAL BACKGROUND 
The two components to the electromagnetic field, which are electric field and variation of the 
magnetic field, are liable for generation of heat in a tissue. The thermal effects are determined by 
the dielectric properties of the tissue and the magnetic properties of the medium, respectively. As 
discussed in Section 2.3.2, low frequencies (~100 kHz) are best for deep tissue penetration. Since 
biological materials do not have significant magnetic properties, biocompatible MNP are used to 
increase the influence of the variation of the magnetic field. In this project, the emphasis is placed 
on the magnetic component of a low frequency electromagnetic field. The current chapter is 
allocated to literature reviews and describes the background physics as well as definition of basic 
concepts for this project. 
2.1 Nanoparticles in Hyperthermia 
The history of nanoparticles goes as far back as 9th century where ancient Muslim craftsmen used 
the glittering effect of nanoparticles in their products [43]. Today, modern science considers 
nanoparticles a link connecting bulk matter with its atomic or molecular structure. This property 
has led to interest in nanoparticles in such diverse fields as engineering, physics, chemistry and 
biology. In medicine, nanoparticles can be thought of as key elements of a new generation of 
medical diagnosis and treatment tools. For instance, fluorescent semiconductor nanoparticles, 
otherwise known as quantum dots, are used for imaging of biological entities [44]. 
Superparamagnetic nanoparticles are also commercially available as contrast agents for magnetic 
resonance imaging (MRI) to help diagnose various diseases [45].  
In oncology, nanoparticles have successfully been used as anti-cancer drug and gene carriers to 
prevent and control cancer, as well as a detection tools for imaging in cancer diagnosis [46, 47]. 
Their multifunctional characteristic is what makes them great candidates for targeted drug 
delivery and cancer treatment. In the past decade, there has been significant interest in the use of 
nanoparticles for hyperthermia. For localized hyperthermia, nanoparticles such as ‘photo thermal 
gold nanorods’ were used to absorb near infrared irradiation energy and elevate local tissue 
temperature [48]. Gold nanoparticles are biocompatible and have flexible surface composition as 
well as unique optical properties that allow them to be highly absorbent of optical energies [49]. 
Another method called laser-induced thermal therapy employs silica core dielectric nanoparticles 
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coated with ultrathin gold metallic layer, also known as nanoshells, to absorb near infrared 
energy and convert this energy to heat [50]. Electromagnetic fields within the frequency range of 
tens of megahertz have also been used to generate heat using iron doped gold nanoparticles [49]. 
Other types of nanoparticles such as La0.7Sr0.3MnO3 have also been used to generate heat once 
exposed to a microwave applicator [51].   
MNP from metals such as iron, cobalt and nickel and their alloys are useful due to their 
magnetically induced and multifunctional properties. These nanoparticles are able to create heat 
once placed in an external AC magnetic field. Among different chemical compositions of MNP, 
iron oxide has been given special attention for hyperthermia. That is due to its proven 
biocompatibility, biodegradability and low toxicity [52]. Iron oxide particles for magnetic 
hyperthermia were first suggested in 1957 [53]. Since then other MNP compounds such as iron 
cobalt with particularly higher magnetization than iron oxide have been suggested [54]. Iron 
cobalt has shown higher induction efficiency than iron oxide, however due to unknown toxicity 
issues of this magnetic compound further investigation is required before it can reach human 
clinical trials. Various compositions such as Cu-Ni, Gd-substituted Mn-Zn ferrite, CoFe2O4, and 
Mn-Zn ferrite have also been used for the purpose of hyperthermia [55-58].  
2.2  Heat Generation of MNP Inside an AC magnetic field 
The heat generated by the MNP inside of an alternating magnetic field (AC magnetic field) is 
mainly caused by three major mechanisms; hysteresis loss,  Néel and Brownian relaxations. 
Particle size, shape, composition, concentration and viscosity of the suspension medium as well 
as magnitude and frequency of the applied magnetic field determine the relative strength of each 
of these mechanisms.  
2.2.1 Magnetic Domains 
Large magnetic materials consist of several domains in order to minimize magnetostatic energy 
of the material. The magnetostatic energy is the energy of the magnet in its own field. In the 
System of International (SI) Units, magnetostatic energy is given by     
! where 
! is an 
element of the volume, " is the magnetic field and the integration is evaluated over all space 
[59]. As shown in Figure 2.1 [59], by splitting the
  14 
 
of the " field decreases. This is because as the number of domains increase, the north and the 
south poles become closer and therefore it reduces magnetostatic energy of the material. 
 
Figure  2.1. Magnetostatic energy reduces as crystal is split into domains 
The boundary separating the two neighbouring domains is called a domain wall. Each domain 
contains large numbers of atomic magnetic moments, m created by microscopic current related to 
the spin of the electrons. Indeed, all materials are classified by the orientation of their magnetic 
moments and form various types of magnetism mainly known as ferromagnetism, 
ferrimagnetism, antiferromagnetism, paramagnetism and diamagnetism. The complete theory of 
magnetism is well beyond the scope of this introduction. However, Figure 2.2 [60] illustrates the 
orientation of the magnetic moments for these types of magnetism.  
Magnetic moments of ferri-, ferro- and antiferromagnetic materials are aligned with each other 
below a critical temperature – the Curie temperature – to reduce the exchange energy of the 
material. The exchange energy is caused by the interactions among internal magnetic moments. 
According to the Weiss domain theory [61], the direction of the aligned moments varies from 
domain to domain, and in the absence of an external magnetic field this direction is aligned along 
magnetic crystallographic axes called ‘easy axes’. In fact, domain walls consist of smooth 
gradual rotation of the direction of the m vectors within the crystal shown in Figure 2.3 [60].  
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Figure  2.2. Different types of magnetism 
The spin-orbit coupling, meaning interaction between spin and the orbital motion of each 
electron, exhibits a resistive force against any attempt by an external magnetic field to rotate the 
spin axis. The energy required to overcome the spin-orbit coupling that keeps particles 
magnetized in a specific direction is called anisotropy energy, E = KV, where K is the effective 
anisotropy constant and V is the volume of the magnetic core [59, 62]. The anisotropy constant is 
a sum of several terms such as magnetocrystalline, shape and surface anisotropy as well as 
dipole-dipole interaction between the crystals [63]. Here, it is assumed that the MNP have 
spherical shapes and are mono-dispersed in solvent with low volume fractions. Therefore 
magnetocrystalline and surface anisotropy contribute the most to the effective anisotropy constant 
of MNP. 
 
Figure  2.3. Presentation of domain wall 
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As the external magnetic field strength increases, the net m vectors of the domains of a ferri- and 
ferromagnetic material become more aligned with the external magnetic field direction to 
minimize the crystal potential energy and cause displacement of the domain walls. Figure 2.4 
[59] shows that as the external field strength becomes larger, the magnetic moments opposing it 
become smaller. If the external field is high enough, it can align all m vectors to the magnetic 
field direction and the material can act as a single domain particle with a unidirectional magnetic 
moments. 
 
Figure  2.4. Multi-domain material inside applied external magnetic field 
In this investigation, ferrimagnetic iron oxide (magnetite) nanoparticles were chosen. As shown 
in Figure 2.2, these nanoparticles display lower magnetic response compare to ferromagnetic 
materials. This is because a ferrimagnetic material consist of m vectors that are not all aligned in 
one direction, therefore the net m vector is smaller than that of a ferromagnetic material where the 
m vectors are all aligned in one direction. However, in addition to magnetite biocompatibility and 
low toxicity advantages, these particles are less sensitive to oxidation than ferromagnetic 
materials and therefore maintain stable magnetic behaviour [60] in rich oxygen environments 
such as in a human body.  
2.2.2 Hysteresis 
The energy from exposure to moderate external field H (Figure 2.5 point 1) [60] leads magnetic 
moments to overcome the anisotropy energy. This results in an irreversible sudden rotation of the 
magnetic moments into a new set of magnetic crystallographic axes. These axes are nearest to the 
external field direction. The directions of the moments within domain walls are indeed a balance 
between exchange and anisotropy energies. Therefore a change in the external field energy can 
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alter this balance and cause moments to rotate. Further increase in field amplitude leads to 
saturation of magnetization MS of the magnetic moments (Figure 2.5 point 2) and a reversible and 
gradual alignment with the external field direction and hence creation of a sample that acts as a 
single domain [61]. The MS value for a bulk matter is different for nanoparticles of the same 
material. For example, experimental values for MS of magnetite nanoparticles are between 30 – 
60 emu g-1, whereas this value for the bulk magnetite is reported to be as high as 92 emu g-1 [60]. 
The reason for such difference is not entirely clear and still under investigation. By reducing the 
applied magnetic field to zero, magnetization M of the domains decreases gradually to remanent 
magnetization – MR (Figure 2.5 point 3). The magnetization can be reduced to zero by applying a 
magnetic field in the opposite direction and a magnitude equal to the coercive field HC (Figure 
2.5 point 4). At this point domains are demagnetized completely, but they can gradually begin to 
realign in the opposite direction if the external field is increased in the negative direction and 
reaches MS (Figure 2.5 point 5). Once again, by reducing the external field to strength zero, 
magnetic moments reach MR in the negative M axis (Figure 2.5 point 6). An applied magnetic 
field magnitude equal to coercive field HC in the positive direction will bring magnetization to 
zero and further increase of the field amplitude in this direction will trace the curve back to 
positive MS (Figure 2.5 point 2). As shown in Figure 2.5, the magnetization curves for increasing 
and decreasing magnetic field amplitudes do not coincide and therefore the material demonstrates 
“hysteresis behaviour” – hysteresis is a Greek word for ‘a coming late’ – and hysteresis losses are 
expressed in the form of heat dissipated to the surrounding medium.   
 
Figure  2.5. Hysteresis curve of a multi-domain particle 
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In the case of fine ferri- and ferromagnetic single domain particles, such as iron oxide and cobalt 
respectively, thermal agitations are ignored when the difference between the maximum and the 
minimum energy per unit volume, set by the anisotropy energy of the particle, is larger than its 
thermal energy kT, where k is Boltzmann constant. Stoner-Wohlfarth’s calculations [64] 
demonstrate a narrow hysteresis curve for these single domain magnetic particles. When an 
external magnetic field is applied to magnetize and demagnetize such particles, energy is released 
in the form of heat. As in multi-domain particles, when the external magnetic field amplitude is 
larger than the anisotropy field, the anisotropy energy barrier is overcome and the magnetic 
moments will rotate onto the anisotropy axis closest to the external magnetic field direction. 
Further increase in the external field will lead to gradual alignment of the net magnetic moment 
with the external magnetic field direction until saturation. Figure 2.6A demonstrates this 
phenomenon. In this Figure, dashed lines represent the magnetic moments of the particle and 
solid lines represent the dominant ‘easy axes’. When external field H is applied, the magnetic 
moment follows the field direction. Once the external magnetic field is removed, the magnetic 
moment takes a certain time to rotate back to its original lower energy ‘easy axis. Release of heat 
is therefore due to the fact that magnetisation here lags the applied external field.  
 
Figure  2.6. Relaxation Mechanisms 
Dashed lines represent the magnetic moments of the particle and solid lines represent the dominant ‘easy axes’ 
2.2.3 Superparamagnetic Nanoparticles 
In smaller single domain magnetic particles, called superparamagnetic nanoparticles – less than 
20 nm in diameter for Iron Oxide Fe3O4 (Magnetite) MNP [65] – the difference between the 
magnetic moment maximum and minimum potential energy per unit volume of the particle is 
much smaller than its thermal energy kT. The orientation of the magnetic moments of these 
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particles therefore, continuously changes due to thermal agitation [66]. In other words, thermal 
energy becomes significant enough to cause magnetic moments to randomly fluctuate in the 
absence of the energy from an external magnetic field. Due to this behaviour, as shown in Figure 
2.7 measured for iron oxide nanoparticles, these particles seem to lack hysteresis losses. 
However coercive fields HC do not rest at zero. Therefore an extremely narrow hysteresis loss is 
formed which contributes into release of heat within superparamagnetic nanoparticles. 
 
Figure  2.7. Hysteresis curve of a iron oxide superparamagnetic particle 
2.2.4 Relaxation Mechanisms 
By applying a moderate external magnetic field to superparamagnetic nanoparticles, the energy 
from the field drives the magnetic moments to rotate and aligns them with the magnetic field 
direction by overcoming the thermal energy barrier. Once the external magnetic field is removed, 
magnetic moments do not relax immediately but rather take some time to randomize their 
orientations. In fact, according to Néel relaxation mechanism, in superparamagnetic particles the 
alignments and relaxations are responsible for the generation of heat. According to Néel-
Arrhenius equation [67], the time #$ for the magnetic moments to relax and rotate back to their 
thermal equilibrium orientation is given by  
#$  #% exp )*+ , ( 2.1) 
  20 
 
where K is the effective anisotropy constant, V is the volume of the magnetic core, kT is the 
thermal energy and #% is a constant called ‘attempt time’ typically of a value equal to about 10-9 
to 10-11 seconds and is slightly field dependent, however this dependency is usually ignored [68].  
The third mechanism that may contribute to generation of heat within MNP is Brownian 
relaxation. This type of relaxation mechanism causes both multi-domain and single domain 
particles to heat up. In this case, shown in Figure 2.6B, the energy barrier for reorientation of a 
particle is given by rotational friction due to the rotation of the entire magnetic particle caused by 
the external magnetic field torque on the magnetic moment of the particle. Here, by applying the 
external magnetic field H the particle itself is able to turn towards the field direction. Brownian 
relaxation time #-,  is defined by the rotational mobility of the colloidal magnetic particles and 
given by [69] 
#-  3/0+  ( 2.2) 
where η is the dynamic viscosity of the medium in which the particles are suspended and VH is 
the hydrodynamic particle volume. This volume, which is the volume of the magnetic core of the 
particle plus the coating shell around it, represents how the medium perceives the particle. The 
Brownian relaxation time is related to the applied magnetic field through the complex magnetic 
susceptibility. The relationship between magnetization M and the applied magnetic field H is 
expressed below by a parameter called magnetic susceptibility 1   
  1  ( 2.3) 
This parameter explains how magnetization varies with respect to the applied magnetic field. As 
described later, susceptibility consists of a complex (imaginary) and a real component. The 
Brownian relaxation time is accessible from the frequency 234 dependent complex susceptibility 
through the following equation [69]: 
1234   1 %1 6 7 29 3 #- ( 2.4) 
where 1%  is the DC susceptibility.  
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For MNP uniformly suspended in a liquid medium, relaxation times Néel #$ and Brownian #- 
take place in parallel [70]. Therefore the effective relaxation time #:;; or # is given by 
1
#:;; 
1
#< =
1
#> ( 2.5) 
By simulating and plotting relaxation times versus particle size in Figure 2.8, (parameters are 
given in Appendix A.1) for any given radius, it is clear that the shorter time constant dominates 
the effective relaxation time. It is worth mentioning that in highly viscous media, such as thick 
gel or tissue, the inverse of Brownian relaxation becomes very small and therefore the effective 
time becomes dependent on Néel relaxation exclusively. This is further discussed in Section 2.4.  
Relaxation times are temperature dependent. However for mild hyperthermia at near 42ºC, 
relaxation time constants does not alter by much, thus in this investigation the effect of small 
temperature elevations on time constants are considered negligible.  
 
 
Figure  2.8. Relaxation time vs. Particle size for MNP 
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2.2.5 Specific Absorption Rate (SAR) and Specific Loss Power (SLP) 
In hyperthermia, Specific Absorption Rate (SAR) is a measurement of the magnetic power 
absorbed per unit mass of the magnetic material (W g-1). SAR is proportional to the time rate of 
change of the temperature of the magnetic material and given by the following formula [71]:  
   	



   ( 2.6) 
where c is the specific heat capacity of the sample (4185 J l-1 K-1 for water), m is the mass of the 
magnetic particles,  is the total volume and    expressed in ºK s-1 is the temperature increment 
which is experimentally derived from the linear regression of the initial data points seen on in 
Figure 2.9. 
 
Figure  2.9. Temperature vs. time for superparamagnetic magnetite nanoparticles 
Specific loss power SLP is a measurement of the magnetic power loss per unit volume of the 
magnetic material (W m-3). The loss power is transformed into heat and dissipated to the 
surrounding medium. SLP is obtained by multiplying SAR by the density ? (g cm-3) of the 
magnetic material (@A   ). 
According to the first law of thermodynamics, change in the internal energy 
B of an adiabatic 
process (CD  0) is equal to the differential of magnetic work energy W on the system 

B  CD = CF  ( 2.7) 
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B  CF    . 
 ( 2.8) 
Where F is the magnetic work done per unit volume of the magnetic material [70],   is the 
external magnetic field strength and  is the induction flux.  
As seen in Figure 2.10 [72], Equation (2.9) suggests that the change of B also lags behind that of 
H and just as seen in 2.2.2, this lag can cause the magnetic material to exhibit hysteresis.  
 
Figure  2.10. Hysteresis of a magnetic material in B and H axes.   
Integration by parts of each segment of the hysteresis curve in respect to 
F leads to 
F  G   . 
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F  6 O  . 
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Due to co-linearity of the fields, the angel between  and   reduces to zero and therefore the dot 
product vanishes and P and " become magnitudes [70].  
F  6 O P 
" ( 2.11) 
P
 
in Tesla is given by [59] 
P  Q%2" = R4 ( 2.12) 
where R is the magnetization of the material (A m-1) and Q% is the permeability of free space 
(49 T 10JU T m A-1). Substituting Equation (2.12) into Equation 2.11, magnetic work can be 
expressed by 
F  6Q% O2" = R4 
" ( 2.13) 
When magnetization lags the field, the integration yields a positive result indicating conversion 
of magnetic work to internal energy [70], therefore: 
∆B  6Q% O R 
" ( 2.14) 
Therefore, the greater the closed area within the hysteresis loop, the greater will be the internal 
energy.  
As described in Section 2.2.3, superparamagnetic nanoparticles do not exhibit hysteresis. 
However, as described in Section 2.2.4, heat is associated with the energy change through Néel 
relaxation due to magnetization and demagnetization of the superparamagnetic nanoparticles and 
rotation of the magnetic moments in an AC magnetic field. Therefore, Néel relaxation can be 
seen as a form of hysteresis loss for superparamagnetic nanoparticles. For an applied time 
varying external magnetic field  
"24  VW"%VXYZ  "% cos2^4 ( 2.15) 
And, 
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"

  6"%^ sin2^4 ( 2.16) 
Susceptibility on the other hand, consists of both real (Equation 2.18a) and imaginary (Equation 
2.18b) components and are given by [70]  
1  1 a = 71 aa  1 %1 = 7^# ( 2.17) 
1 a  1 %1 = 2^#4 
1 aa  7 ^#1 = 2^#4 1 % 
( 2.18a) 
 
( 2.18b) 
which is dependent on DC susceptibility 1%, angular frequency ^  293 and relaxation time #.  
Magnetization as a function of time is therefore given in the following form:  
R24  VW1 "%VXYZ  "%2 1a cos2^4 = 1 aa sin2^44  2.19) 
Substituting Equation (2.16) and Equation (2.19) into Equation (2.14), the internal energy 
becomes 
∆B  6Q% O "%2 1a cos2^4 = 1 aa sin2^44 26"%^ sin2^44  
  
 Q%"%^ bO 1a cos2^4 sin2^4 = O 1 aa sin2^4 
 c ( 2.20) 
Integrating over one period, 1/3, where 3 is the frequency and equal to  ^/29, the Equation 
(2.20) leads to 
∆B  Q%"%^ e1a sin
2^4
2^ L%f/Y= 1 aa O sin2^4 
g  
 Q%"%^1 aa G sin2^4 

f/Y
%  
( 2.21) 
where only the complex susceptibility component survives the integration.  
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The specific loss power SLP, is equal to the internal energy multiplied by its frequency. 
SLP  ?  ∆B 3  Q%3"%^1 aa G sin2^4 

f/Y
%
 
( 2.22) 
where  ? is the magnetic particle density and 3  is the frequency of the external magnetic field. 
Solving for the above equation  
SLP  ?  Q% 3 "% 9 1 aa ( 2.23) 
Hysteresis loop for ferromagnetic materials differs from a DC magnetic field to an AC magnetic 
field. For constant magnetic field amplitude, as the frequency increases, the area of the hysteresis 
loop increases at first, and eventually decreases [73]. However to avoid complexity, here this 
factor has not been taken into consideration. 
Magnetic nanoparticles prepared with surface stabilizers form magnetic fluids, also known as 
ferrofluids, are suspended uniformly in a carrier liquid. These materials are single domain and are 
superparamagnetic. For such particles, relaxation mechanisms are dominant. From Equations 
(2.23) and (2.18b), SAR is expressed as [70] 
SAR  Q% 3 "% 9 1% 2 9 3 #:;;1 = 22 9 3 #:;;4  
1
? ( 2.24) 
Figure 2.11 (parameters are given in Appendix A.2) plots a simulation of the real and the 
imaginary components of the susceptibility as given in Equation (2.17). These components meet 
at the peak value of  1 aa. In fact, as seen in Equation (2.21), the imaginary component of 
susceptibility is due to the phase difference between the applied magnetic field and the 
corresponding magnetization and therefore is responsible for generation of heat. Moreover, 1 aa
 
reaches its peak value when ^#  1. In the following sections this will help optimize MNP core 
diameter for hyperthermia.   
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Figure  2.11. Susceptibility components vs. Frequency 
2.2.6 Heat Dissipation 
There have been many successful attempts to numerically simulate temperature spatial 
distribution of MNP being excited by an AC magnetic field [74-77]. In each approach, heat 
transfer equations are used to estimate the thermal behaviour inside and outside of a target 
volume. In theory, SAR or SLP from the applied AC magnetic field to magnetic particles that are 
uniformly distributed within a spherical tumour of radius R will dissipate heat to the surrounding 
tissue until temperature reaches steady state. Figure 2.12 demonstrates this concept, in which r 
represents the distance from the center of the spherical volume to a point at infinity. Temperature 
at the surface of the spherical volume is TInitial and reaches minimum temperature TFinal (steady 
state) at distance r = ∞ . It is assumed that the temperature inside the spherical volume is 
constant. 
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Figure  2.12. Temperature vs. Distance 
The tolerable period of exposure of living tissue to an electromagnetic field is limited by 
physiological constraints and depends on the field parameters. Time dependent thermodynamic 
heat transfer equations will help optimize the exposure time required to elevate tissue temperature 
for hyperthermia within the physiological limitations. The following thermodynamic Equations 
[77] were used to sketch a graphical simulation of ∆T as a function of distance for five arbitrary 
time values in Figure 2.13 (parameters are given in Appendix A.3): 
∆2n, 4   A

6q e1 =
rs2 K1 6
n
M =
6
9 rs
tr n G 32u; n, 4w2u; n4
u
x
%
g                         for  0 { n |  ( 2.25a) 
∆2n, 4   A
t
3qn e1 =
6
9 rs G 32u; n, 4w2u; n4

u
u
x
%
g                                                                 for  n }  (2.25b) 
With the abbreviations  
rs  qq r 
?? 
~2u4  2rs 6 14 sin u = u cos u 
32u; n, 4  uJ exp K6 qu?M  T  
u cos u 6 sin u
~2u4 = rsr2u sin u4 w2u; n4  sin 
nu
 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w2u; n4  s2z4 sin +2u; n4 = 2rsr4u sin u cos+2u; n4 +2u; n4  2rrs4
 u n 6 1 
 
Figure  2.13. Time dependent temperature increase as function of distance 
where A is the SLP, q and q represent values of heat conductivity for medium 1 ( for  0 { n | ) 
and 2 ( for  n }  ) respectively,  and  are heat capacity coefficients and ? and ? are mass 
densities for the medium 1 and 2 respectively.  The parameter z is to help integrate from 0 to 
infinity and does not have a physical meaning. The above graph is plotted using a numerical 
integration technique. To estimate thermal effect in various tissues, values of q, , ? for different 
biological tissues can be taken from literature [78]. Each curve in Figure 2.13 represents the 
thermal dissipation with respect to distance from the center of spherical volume for a given time 
interval. As expected, the longer the duration of the magnetic induction process, the higher the 
thermal effect at the center of the spherical volume. Also it can be seen that temperature drops 
rapidly a few millimetres away from the surface of R. This means that in a hyperthermia 
application, unnecessary heat can be kept away from healthy surrounding tissue. 
The following sections in this chapter are allocated for understanding of properties that would 
allow for highest SAR value with minimum dosage of MNP. 
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2.3 Magnetic Properties Suitable For Hyperthermia 
Magnetic properties suitable for hyperthermia are not only governed by the magnetic parameters 
of the MNP but also by the physiological limitations that are set to protect living organisms 
against high magnetic fields. By optimising these properties, maximum SAR and thermal effect 
can be reached and therefore fewer MNP are required at the target area. In this section some of 
the magnetic parameters and limitations are discussed.  
2.3.1 MNP Physical Parameters 
2.3.1.1 Size 
The size of the MNP influences the value of SAR and therefore the thermal effect. As explained 
before, an area within a wide hysteresis loop leads to dissipation of more heat than does a narrow 
hysteresis loop. Assuming constant magnetization saturation MS, coercive field HC defines width 
of the hysteresis loop. There is a relationship between particle core size and the coercive field. As 
shown in Figure 2.14 [59], the HC is at its largest value for particles that are at the border of 
between being single and multi-domain. Superparamagnetic nanoparticles show no hysteresis and 
therefore it is not surprising to see that they do not have any coercive field.  
 
Figure  2.14. Coercive field vs. particle diameter 
Figure above suggests that particles resting on the border between single and multi-domain 
exhibit the highest value of SAR and thus are the best choices for hyperthermia. In a study, 
Zhang et al. [79] showed that due to technical and biocompatibility issues, the applied AC 
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magnetic field is often much lower in amplitude than the field required to saturate all magnetic 
moments of MNP. Conceptually, to benefit from heat generation by a complete hysteresis loop, 
particles have to magnetically saturate to extremely high fields on the order of a few thousand 
Oersted. Such fields may cause unwanted tissue heating, stimulation of peripheral and skeletal 
muscles and irreversible biological effects such as cardiac fibrillation [80]. Therefore, adequate 
magnetic field and frequency necessary to make use of the entire hysteresis loop would be too 
high to consider for hyperthermia. In addition, because an ensemble of multi-domain MNP align 
randomly with the magnetic field, practically only 25% of the ideal maximum theoretical power 
may be dissipated as heat [81].  
According to Okawa et al. [82], under a moderate and physiologically tolerable AC magnetic 
field, the single domain MNP of 18 nm in diameter reached target temperature of 43ºC quicker 
than superparamagnetic and multi-domain MNP. This claim is also in close agreement with the 
findings of Johannsen et al. [83] in which magnetite nanoparticles of 15 nm in diameter were 
used to elevate tumour temperature in vivo tests.  
As mentioned at the end of Section 2.2.5, the imaginary component of susceptibility is 
responsible for the heating of MNP inside an AC magnetic field. It was also shown that this 
component is at its highest value when ^#  1  where ^ is the angular frequency and # is the 
effective relaxation time. In highly viscous media such as tissue, the effect of the Brownian 
relaxation time on the effective relaxation time # is negligible and Néel relaxation time #$  is the 
dominant factor [76]. Using Equation (2.24), Figure 2.15 (parameters and calculations are given 
in Appendix A.4) simulates how SAR due to Néel relaxation behaves as size of the iron oxide 
MNP varies. Frequencies of 20 kHz, 200 kHz and 2 MHz were randomly chosen to display the 
effect of frequency on SAR.  
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Figure  2.15. Power loss due to Néel relaxation vs. radius of MNP 
2.3.1.2 Concentration of MNP 
In steady state temperature difference ∆ is given by [84] 
∆  SAR c 3q  ( 2.26) 
where c is the concentration of the MNP (mass of the particles per tissue volume) and q 
represents the heat conductivity of a tissue volume with a radius R. From the above equation it is 
evident that higher concentration of MNP in the tissue leads to higher ∆. 
Earlier in Section 2.2.1 it was mentioned that one of the factors affecting the effective anisotropy 
constant K is the dipolar magnetic interaction generated by each particle in the external magnetic 
field on the neighbouring particles. Therefore, when the number of MNP is altered, there will be 
a change in the dipolar interaction of MNP. As a result,  change in the concentration of MNP will 
lead to a small change of the K value [85].  This alteration however, is considered insignificant in 
this investigation. 
  33 
 
2.3.2 Limitations to Amplitude and Frequency of the AC magnetic field 
In order to prevent deleterious physiological responses from time varying magnetic fields, there 
are guidelines limiting magnetic field parameters. These guidelines are obtained from scientific 
observations and epidemiological studies.  For biomedical purpose, the frequency of the 
electromagnetic field has to be higher than 50 kHz to avoid neuromuscular electro-stimulation 
and lower than 10 MHz for appropriate penetration [4]. Available experimental data shows that 
the resting human body temperature can be elevated up to 1°C if it is exposed to an 
electromagnetic field that produces a whole-body SAR of between 1 and 4 W kg-1 [80]. Eddie 
current loss produced by closed currents induced by alternating magnetic flux in a conductive 
tissue of sufficient area are responsible for this type of heating [86]. Harmful levels of tissue 
heating can be produced by exposure of the tissue to fields at higher SAR values.  Atkinson et al. 
[87] therefore, established an upper limit of 4.85 x 108 A m-1 s-1  for the product of field 
amplitude (H0) and frequency ( f ) for a single turn induction coil around the thorax of a normal 
size patient. For such body exposure, a tissue load threshold of 25 mW ml-1 was recommended by 
Jordan et al. [86]. Power density absorbed by the tissue is given by 
AX   9 Q
 Q% 2 3nH%                                2W mJt4 ( 2.27) 
where µ is the permeability and µ0 is the permeability of free space, σT is the conductivity of the 
tissue, f stands for frequency, H0 is the external field strength and r is the distance from the 
central axis of the body. Using the above equation and the upper limit to the product of the field 
amplitude and frequency, the following graph (Figure 2.16) is simulated and plotted (parameters 
are given in Appendix A.5).  
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Figure  2.16. Biological limitation to field and frequency 
In the above graph, the curve represents the upper limit for H0 and f that can be used for patients 
with a body cross section of 10 centimetres in radius at tissue load limit of 25 mW ml-1. This 
simulation also took into account values for biological tissue conductivity ranging from 0.0144 S 
m-1 to 0.68 S m-1 as tabulated in [78] for frequencies in the range of 100 kHz to 1 MHz. Since 
eddy current power density is proportional to the square of the diameter of the induced current 
loops, the proposed upper limit can be accordingly larger for smaller body regions under AC 
magnetic field exposure. For example, a higher limit of H0 x f = 4 x 109 A m-1 s-1 has been 
suggested for treatments of the breast cancer [88]. 
When an electromagnetic wave passes through the human body, as it heats the tissue it also 
declines in intensity. This is given by 
  %exp 262  4                       2W mJ4 ( 2.28) 
% | 100     2W mJ4 maximum safe incident intensity  /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where I is the power per unit area transmitted through the tissue, x is the penetration depth of the 
tissue,  is the total attenuation factor including scattering and absorption.   is the incident 
frequency and  averages ~5 T 10Jt sec1/2m-1 for soft tissue [89]. According to Equation 2.23, 
at 1000 MHz (microwave) more than 90% of power is lost in approximately 15 mm depth of the 
soft tissue; at 30 GHz incident power has lost 99% of its energy in less than 10 µm depth in the 
tissue. On the other hand, 67% of the energy is passed through a thickness of 10 cm tissue un-
scattered and un-absorbed at 160 kHz. This suggests a suitable frequency range (~100 kHz) for 
proper penetration of the AC magnetic field and excitation of the MNP at a deep target area. To 
simplify calculations, here the biological load is assumed to be isotropic and homogeneous and 
its cross section exhibits cylindrical symmetry to the induction coil. Also the magnetic field 
within the coil and tissue load is assumed to be uniform and field penetration into the dielectric 
material is complete. Moreover, the tissue under study is far away from any metalic implants that 
could affect the field in any way. Last but not least, it is assumed that there is no axial electric 
field within the coil.  
In addition to the above, a study involving electromyography recording of human arm [90] 
showed that a derivative of the AC magnetic flux density -  greater than 10
4
 T s-1 was required to 
stimulate the median nerve trunk. As simulated and shown in Figure 2.17, an AC magnetic field 
of 4500 A m-1 at 160 kHz is far from this limit and could not stimulate median nerve trunk.  
 
Figure  2.17. dB/dt for Frequency = 160 kHz and Field = 4500 A m-1 
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2.4 Hydrogel Encapsulated MNP 
Hydrogels are polymers that are able to absorb large quantities of water without dissolving or 
losing their three dimensional structure. They are used in biomedical applications because their 
physical properties are similar to those of living tissue and they are highly biocompatible. Some 
hydrogels are known as “smart” gels due to their response to an external stimulus, such as change 
in temperature, pH, magnetic fields, etc. Thermo-responsive hydrogels are particularly of high 
interest in which N-isopropylacrylamide (PNIPA) hydrogel is the most familiar type. PNIPA has 
an inverse response to temperature elevation, that is, it reduces size when heated and swells when 
cooled down [11]. This discontinuous and reversible mechanism caused by internal structure 
changes due to the presence of hydrophobic groups occurs at lower critical solution temperature 
(LCST). At temperatures below LCST (Figure 2.18), hydrogen bonds between hydrophilic 
groups of the polymer chain are dominant, i.e. dissolution of water has increased. When 
temperature is increased to LCST (Figure 2.19), hydrogen bonds become weak and hydrophobic 
interactions become stronger, which results in a change in the internal structure, so water is 
expelled out of the hydrogel. This phenomenon results in color change (become opaque) and 
volume change. The LCST of PNIPA hydrogel alone is at 32°C, and can be set above body 
temperature by copolymerization with hydrophobic monomer like acrylic acid [91, 92] 
 
 
 
Figure  2.18. PNIPA at Temperature less than LCST Figure  2.19. PNIPA at Temperature greater than LCST 
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2.4.1 MNP Embedded in PNIPA Hydrogel for Drug Delivery 
As described before, induction of MNP can provide the necessary heat for hydrogel to shrink and 
reduce its volume. In this case, as illustrated in Figure 2.20, MNP are embedded within the gel 
and assist in elevation of hydrogel temperature once placed in an AC magnetic field. There, the 
energy from the magnetic field is transformed into heat and then transferred from the MNP to the 
hydrogel, thus increasing its temperature. The LCST was determined to be 29°C. The interaction 
between MNP and/or the polymer coating with the hydrogel may have had an effect on reduction 
of LCST. 
 
Figure  2.20. MNP embedded in PNIPA hydrogel 
The goal here is to integrate MNP with therapeutic agents in micro-carriers made of PNIPA 
hydrogel that are capable of transiting through the very small diameter blood vessels of the 
human vasculature. These micro-carriers can be navigated towards a target such as a tumour 
using a gradient magnetic field of a clinical MRI. As depicted in Figure 2.21a, instead of relying 
on one large magnetic core to propel and steer such micro-carriers in the vascular network, the 
proposed hydrogel micro-carriers rely on an agglomeration of the MNP embedded within the 
hydrogel.  As such, the MNP are also used for propulsion through an induction of the magnetic 
gradients generated by a clinical MRI system. This also allows tracking of the micro-carriers as a 
local distortion of the magnetic field inside the MRI system, where the confirmation of the 
homogenous distribution of the micro-carriers within the target volume prior to drug release 
would be feasible [38]. Once the micro-carriers are immobilized by means of embolization 
(Figure 2.21b), an AC magnetic field can cause the embedded MNP to heat the PNIPA hydrogel 
and as such, actuate a drug release sequence. At this time, as a result of a reduction in hydrogel 
volume, a fraction of the embedded MNP, H2O, and therapeutic agents can be liberated, allowing 
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the micro-carrier to move closer to the target area. In addition to the influence of therapeutic 
agents on target cells, released MNP around the target area can be made to bond with the target 
tissue surface and cell membranes by means of antibodies. The change of target tissue surface 
may cause a change in the topography cues of the environment and target cells where it may 
influence cell cytoskeleton formation and encourage the cells to switch from growth to apoptosis 
[37]. 
 
Figure  2.21. PNIPA- MNP as hyperthermic actuator for drug delivery in the vascular network 
 
2.5 MNP and the Gradient Magnetic Field 
As seen in the Figure 2.20, the gradient of the magnetic field in MRI steers the micro-carriers to 
the target tumour. The torque and the force created by an MRI magnet can be calculated from 
[61] 
#  Q T N    T N (2.29) 
  2. 4N (2.30) 
  39 
 
In the above equations, # is the magnetic torque (N.m),  is the magnetic force (N),  is the 
magnetization of the material (A m-1), V is the volume of the magnetic material (m3), N is the 
magnetic induction (T) and N  is the gradient (spatial variation) of the magnetic induction (T 
m
-1). It is seen from Equation (2.30), that the magnetic force required to steer micro-carriers in 
Figure 2.21 is not dependent on the size of the individual nanoparticle but the volume of an 
ensemble of the MNP within the micro-carriers. Size of the MNP however, has direct impact on 
change of temperature upon exposure to the AC magnetic field. Therefore, there are no size 
related constrains for propulsion of an ensemble of MNP encapsulated inside micro-carriers that 
are functionalized for moderate hyperthermia.  
Rigid objects such as micro-carriers face a drag force by the moving fluid in a rigid cylindrical 
tube such as the blood vessels. This force is dependent on the fluid density, velocity of the object, 
frontal area and the ratio of the object diameter to the cylinder diameter. Micro-carriers can be 
propelled by the gradient field force if this force is stronger than the drag force of the blood flow 
on the micro-carriers.  In this regard, a 1.5 mm ferromagnetic bead was navigated through the 
carotid artery of a living swine by the gradient of a 1.5T clinical MRI [93]. This important 
realization opens new doors to a navigable hyperthermic based drug release mechanism.  
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CHAPTER 3 EXPERIMENTAL METHODS 
In this chapter, experimental methods are presented to validate and support the theoretical 
explanations as well as the mathematical simulations shown in the previous chapters.   
3.1 Induction Heating Machine 
To obtain a sinusoidal AC magnetic field on the order of a few tens of amperes per meter at 
hundreds of kilohertz, a 1.5 kW induction heating machine was allocated from Norax Canada Inc. 
This machine, shown in Figure 3.1, is originally engineered to induce eddy currents on the metal 
surface and heat it near to the melting point. The eddy current is generated by tens of amps at 
relatively high frequencies through a cylindrical copper tube coil surrounding the metal. The 
device is cooled down by cold water.  
 
Figure  3.1. Norax Canada Inc. induction heating machine 
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Following the convincing results from preliminary tests with the device shown in the Figure 3.1, 
a more sophisticated induction heating machine was purchased from Ameritherm Inc™. This 
device, shown in Figure 3.2, consists of a 2 kW amplifier, a heat station and an induction copper 
tube coil. The coil is attached to the heat station and the entire device is cooled by a water-to-air 
cooling system (not shown in the Figure below).   
 
Figure  3.2. Ameritherm Inc™ HotShot 2kW induction heating 
The amplifier is able to run a few hundred amps into the coil through the heat station and 
generate large magnetic fields at a theoretical frequency range of 150 to 400 kHz. The exact 
frequency depends on the inductance of the coil and the matching capacitance inside the heat 
station. This device was selected because of its comparatively low frequency range. As 
mentioned before in Section 2.3.2, at hundreds of kilohertz the penetration of the magnetic field 
in the biological tissue is the largest and suitable for moderate hyperthermia. Necessary 
calculations were done to match the coil dimensions and its inductance with the capacitance of 
the heat station for the minimum available frequency of 150 kHz. A three turn copper tube coil 
was constructed with a diameter of 67 mm and allowed a frequency of 160 kHz. As depicted in 
Figure 3.3, for this frequency, the SAR due to Néel relaxation is at its maximum for magnetite 
nanoparticles of approximately 20 nm in diameter. 
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Figure  3.3. Loss power due to Néel versus radius of MNP at 160 kHz 
Once the frequency is selected, the upper limit of the magnetic field strength can be obtained 
from the mathematically simulated biological limitation curve illustrated in Figure 2.16. This 
upper limit is set to be 4500 A m-1.  
3.2 Experimental Trials 
Commercially available 20 nm magnetite nanoparticles suspended in water were purchased from 
two different companies: micromod and chemicell GmbH. The magnetic properties as well as 
core diameter of these particles were then verified by vibrating sample magnetometer (VSM: 
EV5, Magnetics) and transmission electron microscopy (TEM: Jeol JEM-2100 operated at 200 
kV). Unfortunately, it quickly became evident that the advertised magnetic core size of these 
particles was larger than reality. The images from TEM showed that the nanoparticles consisted 
of sub-particles of much smaller core size. This had major effect on the expected thermal 
behaviour of the nanoparticles and the SAR value never reached its maximum potential.  
3.2.1 Magnetic Fluid 
Magnetic fluid magnetite nanoparticles purchased from micromod (Product number: 79-00-201, 
Rostock-Warnemuende, Germany) were observed by TEM to confirm their crystal structure 
(Fe3O4) and their size distribution. These particles were uniformly suspended in aqueous solution 
and contained 50% dextran polymer as their coating to prevent large dipole-dipole interactions 
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between the MNP. This was verified by the atomic absorption spectrometry (AAS: Thermo 
Scientific S Series). Figure 3.4 demonstrates TEM images from agglomeration of these MNP. 
 
Figure  3.4. Magnetite nanoparticles purchased from micromod 
The images of Figure 3.4 show that the core diameters of the particles vary in a narrow size 
distribution range between 7 to 10 nm. Figure 3.5 illustrates the crystal diffraction patterns 
corresponding to magnetite (Fe3O4) as chemical composition of the particles. 
 
Figure  3.5. Confirmation of magnetite nanoparticles composition 
The VSM reported a magnetization saturation MS value near 43 emu g-1 for these nanoparticles. 
This is almost half of the values found in the literature for bulk magnetite. Other than what was 
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explained in Section 2.2.2, this can be due to the large amount of dextran coating that was 
confirmed earlier by AAS measurements. Coercive field HC was measured to be relatively small 
at 0.88 Oersted (Oe), which is an implication of the superparamagnetic behaviour.   
Magnetic fluid magnetite nanoparticles purchased from chemicell GmbH (Berlin, Germany) were 
also promised to be 20 nm in diameter. These particles came in eight different coatings; Starch, 
Oleic acid, Polyacrylic acid, Poly (maleic acid-co-olefin), Polyvinyl alcohol, SiMAG Carboxyl 
and two types of uncoated MNP: anionic and cationic charge. The images provided by TEM are 
presented below in Figure 3.6 and show that some nanoparticles have different shapes and core 
size distribution.  
 
 
 
a. Starch b. Oleic Acid 
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c. Polyacrylamide d. Poly(maleic acid-co-olefin) 
 
e. Polyvinyl alcohol f. SiMAG, Carboxyl 
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g. Uncoated Anionic h. Uncoated Cationic 
                Figure  3.6. TEM images from chemicell GmbH magnetite MNP 
 
For these MNP, the crystal diffraction patterns corresponded to magnetite Fe3O4 composition. 
The M-H curves provided by VSM show very narrow hysteresis losses and in some cases a 
complete lack of hysteresis losses is evident. These curves are depicted below in Figure 3.7.  
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fluidMAG-OS: Oleic Acid 
  
fluidMAG-PAD Polyacrylamide 
  
fluidMAG-PMO: Poly(maleic acid-co-olefin) 
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fluidMAG-PVA: Polyvinyl alcohol 
  
SiMAG-Carboxyl: Silica, non-porous 
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fluidMAG-UC/C: Uncoated Cationic 
  
fluidMAG-UC/A: Uncoated Anionic 
Figure  3.7. Hysteresis curves of MNP 
 
A brief summary of the coercive field HC, magnetization saturation MS and the initial 
susceptibility are presented below in Table 3.1. The initial susceptibility is the slope of a linear 
portion of the hysteresis curve. The low HC values suggest superparamagnetic behaviour for these 
particles. 
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Table  3.1. VSM measurements for chemicell GmbH MNP 
Sample 
Name 
Sample Coating Lot ID 
Hc 
(Oe) 
Ms 
(emu/g)* 
Initial 
Susceptibility 
M/H 
fluidMAG-D Starch 0104/09 1.517 55.867 9.921 
fluidMAG-OS Oleic Acid, Sodium Salt 0204/09 0.2.67 54.133 16.449 
fluidMAG-PAD Polyacrylamide 0504/09 0.882 64.172 15.810 
fluidMAG-PMO Poly(maleic acid-co-olefin) 0304/09 1.769 60.27 15.865 
fluidMAG-PVA Polyvinyl alcohol 0404/09 2.251 55.867 13.480 
SiMAG-Carboxyl Silica, non-porous 0604/09 0.5.33 55.147 14.762 
fluidMAG-UC/A Uncoated Anionic charge 0704/09 2.164 57.947 16.796 
fluidMAG-UC/C Uncoated Cationic charge 0804/09 1.667 61.920 18.185 
 
* emu/ gram of dried ferrofluid sample 
 
The chemical structure of each coating is provided by chemicell GmbH and depicted in Figure 
3.8. As seen in this Figure, the length and the chemical components of each coating vary. It has 
been suggested that such variety affects magnetic properties of the MNP [60] and therefore has 
an impact on the thermal behaviour. This will be investigated in the following section. 
 
 
 
fluidMAG-D: Starch fluidMAG-OS: Oleic Acid 
 
 
fluidMAG-PAD Polyacrylamide fluidMAG-PMO: Poly(maleic acid-co-olefin) 
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SiMAG-Carboxyl: Silica, non-porous fluidMAG-PVA: Polyvinyl alcohol 
 
 
fluidMAG-UC/C: Uncoated Cationic fluidMAG-UC/A: Uncoated Anionic 
Figure  3.8. Chemical composition of MNP coatings [www.chemicell.com] 
A third set of MNP were specially ordered and custom made by chemicell GmbH from 
fluidMAG-PMO-2 series (Lot ID: 2906/09). The company claimed that these particles have 
larger diameters than previously provided fluidMAG-PMO. Figure 3.9 shows the crystal 
diffraction pattern obtained from TEM and suggests magnetite Fe3O4 as chemical composition of 
these particles.  
 
Figure  3.9. TEM image and diffraction patterns of fluidMAG-PMO-2 
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From the images of TEM, the diameters of more than 630 single particles were measured and 
recorded. The results are depicted in Figure 3.10 and show a relatively wide size distribution 
ranging approximately from 3 – 18 nm in diameter, peaking at 11 and 13 nm. 
 
Figure  3.10. Size distribution of magnetite nanoparticles 
The VSM measurement shown in Figure 3.11 suggests a value equal to 78.3 emu g-1 for Ms and 
0.14 Oe for Hc. The low coercive field and lack of hysteresis represent the superparamagnetic 
nature of these nanoparticles.  
 
Figure  3.11. VSM for fluidMAG-PMO-2 
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3.2.2 Effect of Concentration on Heat Generation 
The purchased superparamagnetic magnetite nanoparticles from micromod were divided into 
three concentration groups of 10, 25 and 50 mg magnetic particles (MNP plus the coating 
polymer) per ml of suspension fluid by means of distillation. Two 1ml samples of each 
concentration were collected in plastic containers (eppendorfs). Each eppendorf was placed in 
custom made isolation foam (Styrofoam) fitted for the inside of a 15 mm diameter, 8 turn copper 
tube induction coil. The 1.5 kW induction machine shown in Figure 3.1, provided a magnetic 
field near 80 kA m-1 (~1000 Oe) at a frequency of 150 kHz inside the coil.  Temperature changes 
were monitored and recorded at every 15 seconds for a period of 900 seconds (15 minutes) by 
two thermocouples (T-Type, Omega HH506R). A thermocouple measured the temperature of the 
sample and the other measured the temperature of the Styrofoam as shown in Figure 3.12.  
 
Figure  3.12. Experimental setup concentration effect on heat 
Prior to any test, 1ml of deionised water was placed inside the coil to measure the effect of the 
AC magnetic field on the suspension media, the thermocouples, the eppendorf and the 
Styrofoam. Such effect was measured to be negligible for this experiment. The tests were carried 
out twice for each sample and the results are averaged and presented in Chapter 4. 
3.2.3 Effect of MNP Coating on Heat Generation 
In this experiment magnetite nanoparticles purchased from chemicell GmbH with eight different 
coatings were placed in a 2 kW induction heating machine shown in Figure 3.2. The primary 
purpose of this experiment was to see how various coatings would influence the temperature rise 
of the MNP. Considering that only a handful of coatings were examined and as seen in Figure 3.6 
the core diameters of the MNP were not always consistent, the results were not entirely 
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conclusive. The idea here however, was to find what type of coating among available samples 
would allow for maximum generation of heat. Therefore, 0.5 ml MNP samples of the various 
coatings with a concentration of 25 mg/ml were prepared in separate eppendorfs. Each sample 
was placed in a custom made isolation foam (Styrofoam) fitted for an inside of the copper tube 
coil seen in Figure 3.2. This coil was designed to generate a magnetic field strength of 2 kA m-1 
at 160 kHz. Fibre optic temperature sensors (Reflex, SN: T18 217A, Neoptix© Inc, QC, Canada) 
recorded temperatures of the sample as well as a distance of 1 and 2 centimetres away from the 
center of the eppendorf every 15 seconds for a total time of 3000 seconds. The results were also 
used to validate thermodynamic theory of the time dependent change of temperature as a function 
of distance presented in Section 2.2.6 and shown in Figure 2.13. A control sample containing 
deionised water was placed inside the coil to measure the effect of the AC magnetic field on the 
thermocouples, the eppendorf and the isolation foam. This effect was found to be negligible. 
3.2.4 Magnetic Fluid and Heat Generation 
Results from previous experiment led to the purchase of magnetite nanoparticles fluidMAG-
PMO-2 (Lot ID: 2906/09). As described in Section 3.2.1, these particles were larger than the 
former fluidMAG-PMO (Lot ID: 0304/09). For this experiment, as shown in Figure 3.13 and 
Figure 3.14, 1ml sample of fluidMAG-PMO-2 with concentration of 25 mg/ml was placed in a 
Cryogenic vial.  
 
Figure  3.13. Heating of fluidMAG-PMO-2 on hot plate at 37ºC 
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The vial was then suspended in the middle of the copper coil and inside a Pyrex® beaker that 
contained 170 ml of deionised water via a plastic suspension support.  The beaker was placed on 
a hot plate with a magnetic stirrer device (Isotemp®, Fisher Scientific, Iowa, USA) and the 
temperature was set to 37ºC to imitate the environment of a human body. Water temperature was 
kept constant at 37ºC via a thermocouple connected directly to the hot plate and was monitored 
continuously via a third party fibre optic sensor. To imitate a moderate blood flow, a small 
cylindrical magnetic stir bar 6 x 6 x 15 mm was dropped to the bottom of the beaker and set to 
spin at 50 rpm. This speed was artificially chosen to create constant flow.  
 
Figure  3.14. Induction heating setup for fluidMAG-PMO at 37 ºC 
The coil was powered by an induction heating machine via a heat station and it was designed to 
generate a field equivalent to 4.5 kA m-1 at 160 kHz. This is in agreement with tissue limitations 
that can be seen in Figure 2.16. Room temperature and temperature of the sample were measured 
every 10 seconds for a period of 1080 seconds (18 minutes), with the help of fibre optic sensors 
(Reflex, SN: T18 217A, Neoptix© Inc, QC, Canada). A control sample containing deionised 
water was also placed inside the coil to measure the effect of the field on thermocouples, vial, 
plastic suspension support and the beaker. This effect was found to be negligible. The experiment 
was repeated 3 times and the results are explained in the following chapter.  
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3.2.5 Hydrogel Encapsulated MNP 
For this experiment, temperature response of PPNIPA hydrogel embedded MNP (PPNIPA-MNP) 
inside an AC magnetic field was tested. To avoid a rapid dissipation of heat to the surrounding 
area, the test subjects were placed first in a 5% w/v agar gel, and second in a thermal insulation 
Styrofoam. 
To create agar gel, 10 grams of agar powder (Agar, Technical) was added to 200 ml deionised 
water. The solution was stirred and heated to 80°C and then left to cool to room temperature for 
an hour. The final gel was cut to fit inside an induction coil seen in Figure 3.15. A hole was then 
made in the middle of the agar to fit the shape of the eppendorf. The PPNIPA-MNP samples were 
synthesized using a method described in [94]. Two sets of PNIPA-MNP samples were prepared 
from two concentrations of 5 and 10 mg magnetite/ml ferrofluids of dextran coated MNP 
purchased from micromod (Section 3.2.1). Samples were placed in the eppendorfs with 7.0 mm 
internal diameter and 40.3 mm in height. Each eppendorf contained 0.5 ml PNIPA-MNP. A set of 
PNIPA hydrogel without any MNP was also synthesised to see the effect of the AC magnetic 
field on the polymer alone. Eppendorfs were carefully placed in the center and inside of the agar 
gel so that the samples could be buried below the agar top surface. For this experiment the agar 
gel was put in the middle and inside a 3 turn custom made copper tube coil with a diameter of 67 
mm. The coil was powered by an induction machine (Amertitherm Inc.™) shown in Figure 3.15 
to generate a magnetic field of 9.2 kA m-1 (~116 Oe) at 145 kHz. The magnetic parameters fall 
below the H0 x f  limit range (4 x 109 A m-1 s-1) suggested for treatments of the breast cancer and 
explained in Section 2.4.2. 
 
Figure  3.15. Induction of hydrogel sample in agar gel 
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Temperatures of the hydrogel samples and the agar gel at a distance of 1 centimetre away from 
the center of the eppendorf were recorded every 10 seconds by fibre optic temperature sensors 
(Reflex, SN: T18 217A, Neoptix Inc, QC, Canada). The induction machine was turned on 10 
seconds after starting time for temperature recording and turned off after 30 minute for each 
sample.  
In the second part of this experiment (Figure 3.16), Styrofoam was used. Styrofoam minimizes 
the effect of possible external temperature fluctuations due to coil or variation of room 
temperature by thermally insulating the sample. As such, each eppendorf was placed in the 
cylindrical Styrofoam with 27 mm in diameter and 45 mm in height such that the eppendorf was 
completely insulated by the Styrofoam. The Styrofoam was then placed at the center of the 
copper tube coil. Variations of temperature inside the eppendorf as well as the Styrofoam at a 
distance of 1 centimetre away from the center of the eppendorf were recorded every 10 seconds 
for 30 minutes via fibre optic temperature sensors. 
 
Figure  3.16. Schematics of the induction of the hydrogel sample in a Styrofoam insulation. 
Finally, to visualize volume change of PNIPA hydrogel samples, a 20 mm3 PNIPA hydrogel 
containing 10 mg magnetite/ml of PNIPA hydrogel with lower critical solution temperature 
(LCST) of near 29°C was placed inside a channel fabricated on Poly(methyl methacrylate) or 
PMMA and seen in Figure 3.17. The PNIPA hydrogel was then heated on a hot plate to 29°C. 
Temperature readings were taken by an infrared thermometer (Oakton, TempTestr IR) and 
change of volume was observed by a microscope. Results are provided in the next chapter.  
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Figure  3.17. Hydrogel encapsulated MNP inside PMMA channel 
3.2.6 Spherical Hydrogel Encapsulated MNP 
The hydrogel encapsulated MNP (PNIPA-MNP) are synthesized using a method similar to the 
one described in [94]. For this experiment, as illustrated in Figure 3.18, the PNIPA-MNP are 
made into small spherical shapes of about 1 mm in diameter that contain 2 wt% magnetite 
nanoparticles. The fluidMAG-PMO-2 (Lot ID: 2906/09) are used as the MNP embedded within 
the hydrogels. Nearly 100 of these hydrogels were placed in a 2.0 ml Cryogenic vial. The vial 
was then filled with deionised water until the total volume was 0.5 ml. The vial was placed at the 
center of a Styrofoam fitted for inside of the copper coil similar to the one shown in Figure 3.15. 
The PNIPA-MNP were excited by an AC magnetic field strength of 4 kA m-1 at 160 kHz. The 
magnetic parameters respect physiological field limitations shown in Figure 2.16. Fibre optic 
temperature sensors (Reflex, SN: T18 217A, Neoptix© Inc, QC, Canada) were used to measure 
the temperature change for a period of 1500 seconds (25 minutes). The experiment was carried 
out 5 times and the results are discussed in the following chapter.  
 
Figure  3.18. Spherical hydrogel encapsulated MNP 
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CHAPTER 4 RESULTS 
4.1 Effect of Concentration on Heat Generation 
As described in Section 3.2.2, three concentration groups of 10, 25 and 50 mg magnetic particles 
(MNP plus the coating polymer) were placed inside a coil providing a magnetic field of near 80 
kA m-1 at a frequency of 150 kHz. Temperature increments as a function of time are depicted in 
Figure 4.1.  
 
Figure  4.1. Concentration effect of MNP on temperature change 
It was observed that for these concentration groups, under the condition where AC magnetic field 
parameters were constant, temperature rose more rapidly as concentration of MNP were 
increased. This was not far from the expectation. Each MNP is thought of as a heat source when 
placed inside the AC magnetic field. By increasing the concentration of MNP, the number of 
these heat sources in the sample is therefore increased and thus higher temperatures are obtained. 
Figure 4.1 shows that the temperature rises following a sub-linear trend initially, then after some 
time the thermal equilibrium between the sample and the surrounding area leads it to plateau.  
Such behaviour is seen in each curve. At every second, energy is absorbed due to the excitation 
of MNP by the AC magnetic field given in J s g-1. As previously seen in Section 2.2.5, via 
Equation (2.6) SAR (W g-1 or J s g-1) can be calculated by multiplying the temperature increment, 
which is experimentally derived from the linear regression of the initial data points  , to the 
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specific heat capacity of water, given by 4185 J kg-1 K at room temperature, and the mass of 
magnetite nanoparticles. Table 4.1 tabulates SAR estimated from the graph of the temperature 
rise as function of time (graphical SAR) using this method.  
Table  4.1. SAR graphical measurement 
 
Concentration: mg (Fe3O4 MNP +50% Coating) per ml Fluid 50 25 10 
mass: mg magnetite per ml Fluid 25 12.5 5 

    (ºC/s) 0.15 0.08 0.03 
Ratio:     [10 mg/ml] : 

    [MNP] 5:1 2.7:1 1:1 
SAR (W/g) 25.67 26.78 25.67 
As seen in Table 4.1,   is steeper for higher mass of magnetite per ml of the sample fluid. 
Theoretically, SAR value is independent of the concentration of the MNP and should be equal for 
all samples. The difference in SAR that is seen above however, could be explained by possible 
experimental errors due to unintentional small changes in the magnetic field or frequency as well 
as slight changes in the room temperature. The value of SAR obtained from this experiment is in 
good agreement with the theoretical predictions seen in Section 2.3.1.1 for particles in range of 7-
10 nm in diameter under an AC magnetic field near 80 kA m-1 at 150 kHz. This is shown below 
in Figure 4.2.  
 
Figure  4.2. SAR due to Néel Relaxation vs. Radius of MNP  
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Using the graphical SAR shown in Table 4.1, ∆T can also be mathematically approximated for 1 
ml spherical tissue volume with a radius  of 6.2 mm using the Equation (2.26) in Section 
2.3.1.2. For this calculation, heat conductivity of the tissue q is assumed 0.146 (W K-1 m-1). The 
results are tabulated in Table 4.2.  
Table  4.2. Theoretical and experimental estimations for ∆ 
Concentration (coating + 
MNP) mg/ml 
Concentration of 
magnetite mg/ml 
Theoretical ∆ Experimental ∆ 
10 5 11.11 14.15 
25 12.5 27.78 35.4 
50 25 55.56 54.7 
 
 
Theoretical and experimental ∆ seem to follow the same incrementing trend line and the values 
are in close agreement.  
Temperature increments as a function of time for this experiment can also be normalized to fit 
second order polynomial equations plotted in Figure 4.3.  
 
Figure  4.3. Second order polynomial normalization of magnetite  
It is important to mention that the   ratios given in Table 4.2 show a linear trend with the 
concentration of magnetite samples. This trend is seen again in normalized second order 
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polymers. In Table 4.3, the concentration ratio referenced at 10 mg of magnetite per ml seem to 
follow throughout the coefficients of the polynomial equations given in the form of     =
   = , where  and  are the coefficients and  represents initial temperature of the sample 
respectively. The small difference may be due to the experimental errors discussed above. 
Table  4.3. Second Order Polynomial Normalization of MNP 
 
MNP 
Concentration 
Ratio 
10 mg/ml : [MNP] Second Order Polynomial 
  [10 mg/ml]:  [MNP]   [10 mg/ml]:  [MNP] 
10 1:1   61.5 T 10J  =  0.03  = 21.6 1:1 1:1 
25 1:2.5   63.9 T 10J  =  0.0732  = 23 1:2.6 1:2.4 
50 1:5   67.2 T 10J  =  0.12  = 24.1 1:4.8 1:4 
In fact, the linear trend seen here may help formation of a systematic relationship between 
concentration of MNP and the final induced temperature for a given time interval. For instance, at 
37ºC, under the same AC magnetic field parameters, the second order polynomial equation could 
be approximated as   60.75 T 10J  =  0.015  = 37 for 1ml sample of the same 
magnetite nanoparticles with a concentration of 5 mg/ml. Figure 4.4 shows that in 900 seconds, 
such approximated trace reaches 44.4ºC. 
   
Figure  4.4. Simulation of temperature as a function of time for 5 mg magnetite /ml fluid 
This is interesting because theoretically temperature falls in the range of temperatures well 
defined for moderate hyperthermia. However physiological limitations to the AC magnetic field 
parameters are not respected in this setup. These limitations are considered for the following 
experimental observations. 
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4.2 Effect of MNP Coating on Heat Generation 
In this experiment, MNP with eight different coatings were excited by the AC magnetic field 
described in Section 3.2.3. Temperature increments as a function of time for all samples are 
depicted in Figure 4.5. Change in temperatures ∆T at distances of 1 and 2 centimetres away from 
the center of the eppendorf containing the magnetite nanoparticles were also recorded. These 
results are given in Table 4.4. 
Table  4.4. Change in temperature at 0, 1 and 2 cm from the center of magnetite sample 
Sample Name ∆T @ 0 cm ∆T @ 1 cm ∆T @ 2 cm 
fluidMAG-PVA 1.66 0.88 0.55 
fluidMAG-D 2.09 1.45 0.83 
SiMAG-Carboxyl 3.12 1.61 1.06 
fluidMAG-OS 3.69 1.86 0.31 
fluidMAG-PAD 3.72 1.47 0.88 
fluidMAG-UC/A 4.43 1.86 1.00 
fluidMAG-UC/C 5.92 2.95 1.56 
fluidMAG-PMO 6.71 3.03 1.45 
 
  
 
Figure  4.5. Effect of coating of magnetite on heat 
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As seen above, magnetite nanoparticles with Poly (maleic acid-co-olefin) coating showed highest 
thermal effect and magnetite nanoparticles with Polyvinyl alcohol coating presented the lowest 
effect. Theoretically speaking, MNP with higher magnetization saturation Ms and initial 
susceptibility χ0 should produce more heat inside an AC magnetic field than MNP with lower 
values of Ms and χ0. High susceptibility means that the magnetic moments within the MNP align 
faster with the field direction and reach Ms at lower applied external field. Assuming narrow 
MNP size distribution for all samples in this experiment, Table 3.1 of Section 3.2.1 suggests that 
magnetite nanoparticles with Polyacrylamide (PAD) coating should introduce highest ∆T. 
However, Figure 4.5 illustrates otherwise. To better understand this, the graphical SAR (W g-1) 
for each sample is calculated and presented in Table 4.5. The area of the hysteresis loops for the 
external field amplitudes between -2 and 2 kA m-1 were also calculated and given in this table. 
From the hysteresis plots in Figure 3.7, magnetisation of the samples at an external field of 2 kA 
m-1 are also estimated and presented in Table 4.5. 
Table  4.5. MNP Coating effect: results and theoretical calculation 
Name 
fluidMAG
-D 
fluidMAG-
OS 
fluidMAG
-PAD 
fluidMAG-
PMO 
fluidMAG-
PVA 
SiMAG-
Carboxyl 
fluidMAG-
UC/A 
fluidMAG-
UC/C 
Coating 
Polymer 
Starch 
Oleic Acid, 
Sodium Salt 
Polyacryl
amide 
Poly(maleic 
acid-co-
olefin) 
Polyvinyl 
alcohol 
Silica, non-
porous 
Uncoated 
Anionic 
charge 
Uncoated 
Cationic 
charge 
Magnetisation 
M @ H=2 kA/m 
(emu/g) 
3.4993 5.9203 5.715 5.7469 4.7825 5.1956 6.5126 5.9409 
Susceptibility 9.921 16.449 15.810 15.865 13.480 14.762 16.796 18.185 
Temperature 
(ºC) @ t=0 s 
23.68 23.98 24.77 24.40 24.66 24.58 24.61 24.51 
Temperature 
(ºC) @ t=3000 s 
25.77 27.68 28.49 31.11 26.32 27.70 29.04 30.43 
∆T= (Tt=3000-Tt=0) 2.09 3.70 3.72 6.71 1.66 3.12 4.43 5.92 
Area of 
Hysteresis loop 
(A/m)
2
 x10
4 
929.41 198.72 716.76 2000.60 1779.50 316.64 2289.30 1750.84 
Hysteresis 
SAR (W/g) 
0.3608 0.0771 0.2782 0.7765 0.6907 0.1229 0.8886 0.6796 
Graphical 
SAR (W/g) 
0.335 0.670 0.763 1.228 0.290 0.558 0.893 1.150 
∆ SAR -0.026 0.593 0.484 0.451 -0.401 0.435 -0.063 0.470 
%  Hysteresis 108 11 36 63 * 22 107 59 
%  Relaxation 0 89 64 37 * 78 0 41 
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The close area within the hysteresis loop (A m-1)2 is placed in the Equation (2.14) to calculate 
SAR (W g-1) due to hysteresis losses. For this calculation, frequency was 160 kHz and the AC 
magnetic field amplitude was 2 kA m-1. In the above table, ∆ SAR represents the difference 
between SAR due to the hysteresis losses and the graphical SAR found from Figure 4.5. 
 Assuming that loss mechanisms are due to hysteresis for those particles that exhibit hysteresis 
losses shown in Figure 3.7, and/or relaxation losses for those lacking hysteresis in the that figure, 
the contribution of each mechanism to the thermal outcome can be estimated by comparing the 
graphical losses to the calculated hysteresis losses. Needless to say, that hysteresis curve is 
different when measured in a DC field than in the AC field. This suggests that the different 
values of SAR due to graphical estimations and hysteresis curves can indeed be related to the 
frequency of the magnetic field. For example, as see in Table 4.5, magnetite nanoparticles with 
starch coating (fluidMAG-D) produce a ∆T of 2.09 ºC that could have been originated entirely 
from the area of its hysteresis curve. Uncoated anionic charged magnetite nanoparticles 
(fluidMAG-UC/A) follow the same pattern, only in this case the area of the hysteresis loop is 
larger than that of the fluidMAG-D nanoparticles and therefore ∆T is larger.  
In the case of oleic acid coated magnetite nanoparticles (fluidMAG-OS), relaxation losses 
contribute nearly 90% of the graphical SAR. Alternatively, uncoated anionic charge magnetite 
nanoparticles (fluidMAG-UC/A) cover nearly 100% of the graphical SAR by hysteresis losses. It 
appears that for samples that hysteresis losses contribute to at least 50% of the graphical SAR, ∆T 
is at its maximum.  This is seen specifically for fluidMAG-UC/C (∆T = 5.92 ºC) and fluidMAG-
PMO (∆T = 6.71 ºC) nanoparticles. This indicates that relaxation and hysteresis losses work hand 
to hand and one complements the other. 
It is also interesting to see that polyvinyl alcohol coated magnetite nanoparticles showed the 
lowest ∆T. This may be surprising since the area within the hysteresis loop for this sample is 
among the highest and relatively similar to that of the uncoated cationic charge magnetite 
nanoparticles. A possible explanation may rest in the TEM image provided in Figure 3.6e. In this 
figure, magnetite nanoparticles are surrounded by nearly 5 nm thick polyvinyl alcohol coating.  
This thick layer is not seen in any other images from the TEM. This protective coating may be 
acting as a thermal isolator and prevent thermal conduction.  
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To validate thermodynamic theory presented in Section 2.2.6, it was assumed that all samples 
were contained within a spherical volume of 0.5 ml. Using Equations (2.25a) and (2.25b), 
theoretical estimation of dissipation of heat from the spherical MNP sample through the 
Styrofoam is plotted in Figure 4.6. The constants required to plot these graphs are given in Table 
4.6. Experimental data points at distances of 0, 1 and 2 centimetres away from the center of the 
spherical volume given in Table 4.4 are also shown in Figure 4.6 in red solid triangles. 
Table  4.6. Constants for the plot of time and distance dependent thermal equations 
Particle mass (g) 12.5 x 10
-3
 
Sample volume (m
3
) 0.5 x 10
-6
 
Radius of the spherical volume (m) 4.924 x 10
-3
 
Power (W m
-3
) SAR T Particle mass
Sample volume   
Heat conductivity of magnetite (W K
-1
 m
-1
) 0.778 
Heat conductivity of Styrofoam (W K
-1
 m
-1
) 0.033 
Density of magnetite (g m
-3
) 1.23 x 10
6 
Density of Styrofoam (g m
-3
) 100 x 10
3
 
Heat capacity of magnetite (J g
-1
 K
-1
) 2.54 
Heat capacity of Styrofoam (J g
-1
 K
-1
) 1.3 
 
For the plots seen below in Figure 4.6, it is assumed that heat did not escape from the top part of 
the eppendorf where temperature sensors were connected. It is also assumed that heat is entirely 
and uniformly transferred to the surrounding Styrofoam, and room temperature does not vary. 
These graphs are plotted without considering the air pockets within the Styrofoam. Last but not 
least, the heat resistance between MNP, water, the plastic wall of the eppendorf and Styrofoam 
are assumed to be negligible.  
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fluidMAG-D: Starch fluidMAG-OS: Oleic Acid 
  
fluidMAG-PAD Polyacrylamide fluidMAG-PMO: Poly(maleic acid-co-olefin) 
  
fluidMAG-PVA: Polyvinyl alcohol SiMAG-Carboxyl: Silica, non-porous 
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fluidMAG-UC/C: Uncoated Cationic fluidMAG-UC/A: Uncoated Anionic 
Figure  4.6. Theoretical estimation of time and distance dependent thermal effect versus experimental 
Despite of the assumptions and the experimental errors such as sudden variation of the room 
temperature, the experimental data was not very far from the theoretical estimations. It is 
apparent that these points would be closer to their corresponding estimated values in a better 
temperature controlled environment with a better knowledge of the magnetic properties of the 
MNP.  
4.3 Magnetic Fluid and Heat Generation 
Poly (maleic acid-co-olefin) coated magnetite nanoparticles used in this experiment are larger 
than those used in the previous experiment. This experiment was set up to examine the thermal 
behaviour of these particles inside a temperature elevated environment such as inside of a human 
body. Temperature increments as a function of time for this experiment are depicted in Figure 
4.7.  
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Figure  4.7. Poly (maleic acid-co-olefin) coated magnetite nanoparticles at 37ºC environment 
The above Figure leads to a graphical SAR (W g-1) value of 0.967 W g-1. This value falls in the 
expected theoretical SAR value shown in Figure 4.8 for magnetite nanoparticles of 3 – 18 nm in 
diameter (see Figure 3.10) in an AC magnetic field of 4.5 kA m-1 at 160 kHz. This value is 
measured to be lower than the previously calculated value of the graphical SAR for Poly (maleic 
acid-co-olefin) coated magnetite nanoparticles given in Table 4.5. The reason for that may lie 
within the complex thermodynamic processes that have affected the dissipation of heat to the 
surrounding areas. For instance, the stirring of the water at 37ºC yielded a constant motion of the 
medium surrounding the outer surface of the vial. Therefore stirring have indeed cooled down 
some of the heat by thermal convection before it could be detected by the temperature sensors.  
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Figure  4.8. Theoretical SAR versus particle size 
In this experiment it was shown that in 18 minutes, 25 mg/ml Poly (maleic acid-co-olefin) coated 
magnetite nanoparticles in a slowly moving fluid could raise body temperature from 37ºC to near 
42ºC. As described in Section 1.2, such elevation of temperature is considered best for moderate 
hyperthermia. Using the method described in Section 4.1.1, the elevation of temperature can be 
mathematically traced with a second order polynomial equation similar to the one shown in 
Figure 4.2. Therefore, by modifying the coefficients of this equation, it is possible to simulate 
thermal behaviour for various concentrations of the same magnetite nanoparticles. This is 
presented below in Table 4.7 and plotted in Figure 4.9 for a time period equal to 1680 seconds (= 
28 minutes).  
Table  4.7. Mathematical simulation of concentration effect on thermal behavour of fluidMAG-PMO-2 
 
Concentration (mg/ml) 
[FluidMAG-PMO-2] 
y = ax
2
 + bx + c Temperature ºC 
@ t = 1680 (s) a b c 
25 -2E-06 0.0066 37 42.44 
27.5 (10% increase) -2.2E-06 0.0073 37 42.99 
32.5 (30% increase) -2.6E-06 0.0086 37 44.08 
  71 
 
 
Figure  4.9. Mathematical simulation of concentration effect on thermal behavour of fluidMAG-PMO-2 
Therefore 30% increase in the concentration of these MNP, at the present experimental setup, 
would lead to a temperature change over 44ºC in about 30 minutes.  
4.4 Hydrogel Encapsulated MNP 
As described in Section 2.4, thermo-sensitive hydrogels called PNIPA are able to reduce their 
volume by releasing water molecules once they are heated above their lower critical solution 
temperature (LCST). PNIPA hydrogel encapsulated MNP (PNIPA-MNP) are able to reach their 
LCST once they are placed inside an AC magnetic field. Therefore, PNIPA-MNP embedded 
drugs can be seen as actuators in hyperthermic drug release mechanism. In this experiment, 
LCST was by default at 29ºC. This value can be adjusted chemically at the time of PNIPA 
synthesis.  
Results in agar gel and Styrofoam are tabulated in Tables 4.9 and 4.10 respectively. 
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Table  4.8. Temperature changes for samples inside agar gel 
AGAR 
T 1 (°C) T 2 (°C) ∆T 
t = 0 s t = 1800 s T2-T1 
PNIPA Hydrogel 17.1 18.5 1.4 
Surrounding (1 cm away) 17.1 18.8 1.7 
5 mg magnetite/ml PNIPA 18.1 21 2.9 
Surrounding (1 cm away) 17.8 20 2.2 
10 mg magnetite/ml PNIPA 18.5 21.8 3.3 
Surrounding (1 cm away) 18.3 20.9 2.6 
 
 
Table  4.9. Temperature changes for samples inside Styrofoam insulation 
STYROFOAM 
T 1 (°C) T 2 (°C) ∆T 
t = 0 s t = 1800 s T2-T1 
PNIPA Hydrogel 25.6 25.8 0.2 
Surrounding (1 cm away) 25.8 26.2 0.4 
5 mg magnetite/ml PNIPA 25.6 27.7 2.1 
Surrounding (1 cm away) 25.6 27.1 1.5 
10 mg magnetite/ml PNIPA 24.7 29.1 4.4 
Surrounding (1 cm away) 25.3 27.8 2.5 
 
 
Previously in 4.1.1, it was observed that higher concentration of MNP led to higher temperatures. 
As expected, 10 mg of magnetite per 1 ml of PNIPA hydrogel led to a higher ∆T than 5 mg of 
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magnetite per 1 ml of PNIPA hydrogel. As seen in Table 9, the temperature of the agar gel was 
always a few degrees Celsius below the room temperature (23°C). This may be due to constant 
liquid evaporation of the agar material at room temperature causing it to be colder. 
The above Tables show that in Styrofoam, the AC magnetic field had little effect on PNIPA 
hydrogel samples with no embedded MNP, whereas inside the agar gel, this effect was seen as 
elevation of the temperature by 1.4°C. Table 9 also shows that temperature of the agar gel 
(surrounding 1 cm away), while PNIPA hydrogel samples with no embedded MNP were 
undergone the AC magnetic field, measured to be 1.7°C. Here, eddy currents generated in the 
agar gel by the induction coil may be responsible for elevations of temperature. The heat may 
then travel to the center of the agar gel and PNIPA hydrogel sample by conduction and raises its 
temperature. A more detailed view of the results for the agar gel and Styrofoam are shown in 
Figure 4.10 and Figure 4.11 respectively. 
 
Figure  4.10. Temperature change versus time for samples inside agar gel 
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Figure  4.11. Temperature change versus time for samples inside Styrofoam 
Once elevation of temperature for the PNIPA-MNP samples was confirmed to be due the 
presence of MNP, change in volume of PNIPA-MNP was tested. At 29ºC, a remarkable change 
of volume in the 10 mg magnetite/ml PNIPA-MNP sample at was observed. For these samples 
the dark red color of PNIPA-MNP (Figure 4.12a) turned grey (Figure 4.12d) and the volume 
decreased substantially to less than 12 mm3 (60% reduction of volume). While cooling, the 
sample regained most of its original volume and was ready to be re-heated.  
 
Figure  4.12. 60% Volume reduction (a-d) of 20 mm3 PNIPA-MNP to less than 12 mm3 when heated to 29°C 
From results of this experiment it may be concluded that the PNIPA-MNP are indeed excellent 
candidates as hyperthermic drug release actuators. These particles could enter the blood stream 
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and locally release drug molecules when heated by an AC magnetic field. They are also able to 
prevent tumour from receiving nutrition supplies by means of embolization. The cooperation 
between MNP, AC magnetic field and thermo-sensitive hydrogels opens new doors to tumour 
therapy. 
4.5 Spherical Hydrogel Encapsulated MNP 
In this experiment, spherical PNIPA-MNP were heated by induction of an AC magnetic field 
with parameters in accordance with the physiological limitations shown in Figure 2.16.  
 
Figure  4.13. 2 wt% hydrogel encapsulated magnetire excited by an AC magnetic field 
As seen in Figure 4.13, the average temperature change ∆T was approximately 2°C in 1500 
seconds. Assuming that the LCST of spherical PNIPA-MNP drug carrying hydrogel is at 39°C, 
the AC magnetic field is able to provide sufficient heat to actuate a drug release sequence 
anywhere inside the human body. This is a step closer to the vision seen in Figure 2.21 in which 
PNIPA-MNP spheres are used for targeted release of therapeutic agents upon exposure to 
inductive heating by AC magnetic field.  
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CHAPTER 5 DISCUSSION 
The motivation behind this thesis was to realize an actuation method for a miniaturised robotic 
system. Such robots navigate in the vascular network to a target tissue such as a tumour and 
actuate therapeutic sequence by heat and/or drug release. In the miniaturization of robots 
navigable inside human body, it is very important to reduce the number of components. This 
reduction can be achieved by increasing the functionality of each component to its maximum. A 
micro-carrier in the human body requires propulsion, tracking and actuation.   
 
Figure  5.1. MNP as navigable and traceable hyperthermic actuator 
The spatial variation (gradient) of the magnetic field is able to apply a force on a magnetic 
material and steer it through the vascular network. According to the Equation 2.25, this magnetic 
force is not dependent on the size of the magnetic material but rather on its volume. Therefore, an 
agglomeration of MNP can also be propelled using the same method. In addition to steering, 
MNP can distort the local magnetic field of an MRI and alter the relaxation times of the water 
protons in the surrounding water molecules and therefore produce a negative MR contrast agent 
[45]. Finally, hyperthermia of MNP inside an AC magnetic field can be used as an actuation 
mechanism and provide a synergistic thermal affect combined with chemo and radiation cancer 
therapies. As an important component of miniaturised robot systems, MNP possess increased 
functionality since they allow propulsion, tracking and actuation as shown in Figure 5.1.  
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Previously in our lab, a 1.5 mm ferromagnetic bead was propelled by the gradient field of a 
clinical MRI [93]. The bead was also tracked through distortions of the image of the MRI [93]. In 
this thesis, hyperthermia of MNP under AC magnetic field as an actuation mechanism for the 
proposed miniaturised robots was investigated. In contrast to other hyperthermia methods, 
hyperthermia via MNP in an AC magnetic field provides advanced control and can be highly 
localized. The experimental results given in Section 4.1, 4.2 and 4.3 and the theoretical 
explanation in Section 2.3 illustrate that by varying the concentration, the coating, the size and 
chemical composition of MNP, thermal behaviour of the particles can be controlled. It was 
observed that temperature rose more rapidly as concentrations of MNP were increased. Also, 
among several types of MNP thermal release was highest when relaxation mechanism and 
hysteresis losses coexisted. Although hysteresis losses were not theoretically expected from 
superparamagnetic nanoparticles, it is suspected that the coating thickness had an influence on 
the width of the hysteresis loops. To validate such conclusion however, further investigations 
beyond the scope of this project are required. For all experiments, it is reasonable to assume 
uniformity of the AC magnetic field due to the small size distribution of the MNP compared to 
the coil dimensions. Also, the samples were positioned in the middle of the field where the field 
is most uniform. Therefore, the variation of the magnetic field is expected to be minimal. 
Thermo sensitive gels called hydrogels were examined in Section 4.4 as potential carriers for the 
next generation of targeted drug delivery. These carriers are able to shrink and release their 
contained liquid with therapeutic agents upon elevation of temperature. Such elevation of 
temperature can be obtained from hyperthermia of the encapsulated MNP within the hydrogels by 
an AC magnetic field. Due to some biocompatibility uncertainties to MNP as well as lack of 
space in miniaturised robots, there are limitations to concentration of MNP. However via 
experiments such as these, for a given target temperature to trigger the release of drugs integrated 
in the micro-carriers, one can predict what concentration of MNP is needed and the time required 
for that temperature to be reached. This further emphasises the candidacy of hyperthermia of 
MNP as an actuation mechanism for the realized robotic systems. The advantage of using MNP is 
that we can adjust the parameters such as the diameter, concentration, coating and the magnetic 
properties such as magnetization saturation.  
As seen in Figure 4.8, SAR reaches a maximum value of 61.02 W g-1 for 20 nm poly (maleic 
acid-co-olefin) coated magnetite nanoparticles inside an AC magnetic field of 4.5 kA m-1 at 160 
  78 
 
kHz. Suppose that these nanoparticles are embedded within drug containing micro-carriers of 50 
µm in diameter and are immobilized in a target volume of 30 mm in diameter by means of 
embolization. To propel the micro-carriers through small veins by the gradient field of the MRI, 
an agglomeration of magnetite nanoparticles occupies 40% of the volume of the micro-carrier. 
Water, hydrogel polymer chains and therapeutic agents count for the remaining 60%. Figure 5.2 
demonstrates this hypothetical situation. 
 
Figure  5.2. Embolization of micro-carriers in the target area 
A computer simulation predicts that after 700 seconds, temperature at the center of the target area 
that contains 110,000 of the proposed micro-carriers would elevate by 3 degrees. Such elevation 
of temperature is sufficient for an actuation sequence to release the therapeutic agents within the 
micro-carriers. After 800 more seconds, the elevation of temperature would be nearly 5 degrees 
which is enough for moderate hyperthermia of the target area. A graphical presentation of this 
simulation is shown in Figure 5.3 (parameters are given in Appendix A.6). As seen in this figure, 
the elevation of temperature decays rapidly as the distance from the center of the target area 
increases. This means that in a hyperthermia application, unnecessary heat can be kept away from 
healthy surrounding tissue. 
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Figure  5.3. Time dependent temperature increase as function of distance 
With the current technology and findings of our investigations, hydrogel encapsulated MNP with 
embedded therapeutic agents are proposed as navigable micro-carriers inside human body. The 
micro-carriers rely on the gradient field of the MRI to be propelled in the vascular network. They 
are also tracked by the distortions they create on the local magnetic field of the MRI. Once they 
have reached the target tissue, hyperthermia of embedded MNP in the AC magnetic field actuates 
a release of the therapeutic agents. By further advancing in MRI imaging, synthesis of hydrogel 
encapsulated MNP, enhancement of the gradient magnetic field of MRI and propulsion 
techniques and functionalising MNP size, coating and magnetic properties, the anticipated robots 
can be traced and navigated in smaller blood vessels and deliver drugs and produce thermal 
targeted therapy. 
5.1 Disadvantages 
Heating is generated by an AC magnetic field whose frequency and strength are limited by the 
physiological human body response to high frequency magnetic fields. These responses are 
stimulations of peripheral and skeletal muscles, possible cardiac stimulation and arrhythmia and 
non-specific inductive heating of tissue.  Development of relatively high frequency magnetic 
field for clinical purposes is an extremely complicated task. Hyperthermia requires a precise 
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delivery of well controlled thermal dose into a complex biological system that is equipped with 
its own thermoregulatory system. Also, toxicity of the particles needs to be carefully studied so 
there would be no toxic residue accumulation in the body after thermal treatment.  
The AC magnetic field does not contribute to the thermal effect of the MNP close to the local 
magnetic field of a clinical MRI. This is because the AC magnetic field is negligible when vector 
sum of the MRI field magnitudes higher than 1 Tesla and the AC field amplitude of a few 
miliTesla are combined. Therefore, after micro-carriers have reached the desired target tissue by 
the gradient of the magnetic field of an MRI, the patient has to be displaced far from the MRI 
field where AC magnetic field could be effective.  
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CONCLUSION 
This evaluation started with a brief introduction to cancer, hyperthermia and several methods of 
hyperthermia as well as advantages of MNP and AC magnetic field. These advantages are not 
limited to heat, tracking and propulsion capabilities of MNP. MNP can be functionalized to target 
specific biological entities by means of antibody coatings and their colloidal ability. Also, 
biological and industrial limitations that lead to a set of magnetic parameters for MNP 
hyperthermia were explained. The effect of the concentration and various coatings of MNP were 
experimentally evaluated on elevation of temperature. Spherical hydrogel encapsulated MNP 
(MNP-PNIPA) were synthesised and heated with induction of an AC magnetic field with 
parameters within the physiological limitations. Propulsion of an agglomeration of MNP by the 
gradient magnetic field of an MRI was previously investigated in our lab. Also, the 
agglomeration of MNP was also tracked by the MR imaging process. Therefore, MNP-PNIPA 
drug carrying hydrogels can also be propelled by the MRI gradient magnetic field to a desired 
target location and be tracked by the MR imaging process. The AC magnetic field is able to 
provide sufficient heat to the embedded MNP to reduce the volume of the hydrogels and actuate a 
local drug release sequence. This is a step closer to hyperthermic targeted release of therapeutic 
agents upon exposure of MNP to inductive heating by AC magnetic field. 
 
 
 
 
 
 
 
 
 
  82 
 
REFERENCE 
[1] G. Karp, Cell and Molecular Biology: Concepts and Experiemnts, 4th ed. NJ: John Wiley, 
2005. 
[2] A. C. Society. (2007, Cancer Facts & Figures. Available: www.cancer.gov 
[3] R. L. Horner MJ, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer 
EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards 
BK, "SEER Cancer Statistics Review, 1975-2006," National Cancer Institute, Bethesda, 
MD, 2009. 
[4] W. E. N. Y. M.-H. Prentice, Arnheim's Principles of Athletic Training: a Competency-
Based Approach. Boston, MA: McGraw-Hill, 2006. 
[5] R. Cavaliere, et al., "Selective heat sensitivity of cancer cells. Biochemical and clinical 
studies," Cancer, vol. 20, pp. 1351-1381, 1967. 
[6] B. Hildebrandt, et al., "The cellular and molecular basis of hyperthermia," Critical 
Reviews in Oncology/Hematology, vol. 43, pp. 33-56, 2002. 
[7] J. Overgaard, "The current and potential role of hyperthermia in radiotherapy," Int J 
Radiat Oncol Biol Phys, vol. 16, Mar, pp. 535-549, 1989. 
[8] RL. Anderson and D. Kapp, "Hyperthermia in cancer therapy: current status," Med J 
Aust., vol. 152, p. 310, 1990. 
[9] R. Engelhardt, "Hyperthermia and drugs," Recent Results Cancer Res., vol. 104, pp. 136-
203, 1987. 
[10] P. Wust, et al., "Hyperthermia in combined treatment of cancer," The Lancet Oncology, 
vol. 3, pp. 487-497, 2002. 
[11] K. L. Ang, et al., "Magnetic PNIPA hydrogels for hyperthermia applications in cancer 
therapy," Materials Science and Engineering: C, vol. 27, pp. 347-351, April 2007. 
[12] A. Dieing, et al., "The effect of induced hyperthermia on the immune system," in 
Progress in Brain Research. vol. Volume 162, ed: Elsevier, 2007, pp. 137-152. 
[13] S. Purushotham, et al., "Thermoresponsive core-shell magnetic nanoparticles for 
combined modalities of cancer therapy," Nanotechnology, vol. 20, 2009. 
[14] J. Zhang and R. D. K. Misra, "Magnetic drug-targeting carrier encapsulated with 
thermosensitive smart polymer: Core-shell nanoparticle carrier and drug release 
response," Acta Biomaterialia, vol. 3, pp. 838-850, 2007. 
[15] S. A. Meenach, et al., "Poly(ethylene glycol)-based magnetic hydrogel nanocomposites 
for hyperthermia cancer therapy," Acta Biomaterialia, vol. In Press, Uncorrected Proof. 
[16] R. T. Pettigrew, et al., "Clinical Effects Of Whole-Body Hyperthermia In Advanced 
Malignancy," The British Medical Journal, vol. 4, pp. 679-682, 1974. 
[17] P. Jiegang, et al., "A Novel Whole-Body Perfusion System for Hyperthermia in 
Oncology," in Bioinformatics and Biomedical Engineering, 2007. ICBBE 2007. The 1st 
International Conference on, 2007, pp. 1080-1083. 
  83 
 
[18] E. A. S. Clare M. C. Tempany, Nathan McDannold, Bradley J. Quade, Ferenc A. Jolesz, 
Kullervo Hynynen, "MR Imaging–guided Focused Ultrasound Surgery of Uterine 
Leiomyomas: A Feasibility Study," ed: Radiology, Vol 226, 2003. 
[19] W. G. Bradley Jr, "MR-Guided Focused Ultrasound: A Potentially Disruptive 
Technology," Journal of the American College of Radiology, vol. 6, pp. 510-513, 2009. 
[20] C. J. Diederich and K. Hynynen, "Ultrasound technology for hyperthermia," Ultrasound 
in Medicine & Biology, vol. 25, pp. 871-887, 1999. 
[21] A. Y. Cheung, "Microwave and radiofrequency techniques for clinical hyperthermia," 
British Journal of Cancer Suppl., vol. 5 Mar, pp. 16-24, 1982. 
[22] Y. Tange, et al., "Heating Characteristics of a RF Hyperthermia for Deep-Seated 
Regions," in Engineering in Medicine and Biology Society, 2005. IEEE-EMBS 2005. 27th 
Annual International Conference of the, 2005, pp. 6770-6776. 
[23] T. S. H. Takahashi, H. Motoyama, T. Uzuka, S. Takahashi, K. Morita, K. Kakinuma, R. 
Tanaka, "Radiofrequency interstitial hyperthermia of malignant brain tumors: 
development of heating system," Experimental Oncology, vol. 22, pp. 186-190, April 20, 
2000 2000. 
[24] G. Carrafiello, et al., "Microwave tumors ablation: Principles, clinical applications and 
review of preliminary experiences," International Journal of Surgery, vol. 6, pp. S65-S69, 
2008. 
[25] S. Banik, et al., "Bioeffects of microwave--a brief review," Bioresource Technology, vol. 
87, pp. 155-159, 2003. 
[26] M. M. Paulides, et al., "Electromagnetic Head-And-Neck Hyperthermia Applicator: 
Experimental Phantom Verification and FDTD Model," International Journal of 
Radiation Oncology Biology Physics, vol. 68, pp. 612-620, 2007. 
[27] K. Engin, "Biological rationale and clinical experience with hyperthermia," Controlled 
Clinical Trials, vol. 17, pp. 316-342, 1996. 
[28] P. R. Stauffer, "Evolving technology for thermal therapy of cancer," International Journal 
of Hyperthermia, vol. 21, pp. 731 - 744, 2005. 
[29] J. C. Lantis Ii, et al., "Microwave applications in clinical medicine," Surgical Endoscopy, 
vol. 12, pp. 170-176, 1998. 
[30] O. A. Arabe, et al., "A 400 MHz Hyperthermia System using Rotating Spiral Antennas 
for Uniform Treatment of Large Superficial and Sub-Surface Tumors," in Microwave 
Symposium, 2007. IEEE/MTT-S International, 2007, pp. 1333-1336. 
[31] M. Urano and E. Douple, Hyperthermia and oncology: Interstitial hyperthermia: physics, biology 
and clinical aspects vol. 3, page 1. Tokyo Japan, 1992. 
[32] A. S. Wright, et al., "Radiofrequency versus Microwave Ablation in a Hepatic Porcine 
Model," Radiology, vol. 236, pp. 132-139, July 1, 2005 2005. 
[33] Byeong-Ho Park, et al., "The Induction of Hyperthermia in Rabbit Liver by means of 
duplex Stainless Steel Thermoseeds," Korean Journal of Radiology, vol. 3, pp. 98-104, 
2002. 
  84 
 
[34] H. Iida, et al., "Synthesis of Fe3O4 nanoparticles with various sizes and magnetic 
properties by controlled hydrolysis," Journal of Colloid and Interface Science, vol. 314, 
pp. 274-280, 2007. 
[35] Q. Pankhurst, "Nanomagnetic medical sensors and treatment methodologies," BT 
Technology Journal, vol. 24, pp. 33-38, 2006. 
[36] T. Neuberger, et al., "Superparamagnetic nanoparticles for biomedical applications: 
Possibilities and limitations of a new drug delivery system," Journal of Magnetism and 
Magnetic Materials, vol. 293, pp. 483-496, 2005. 
[37] C. C. Berry and A. S. G. Curtis, "Functionalisation of magnetic nanoparticles for 
applications in biomedicine," Journal of Physics D: Applied Physics, vol. 36, pp. 198-
206, 2003. 
[38] Ste´phane Mornet, et al., "Magnetic nanoparticle design for medical diagnosis and 
therapy," Materials Chemistry, vol. 14, pp. 2161-2175, Jul 21 2004. 
[39] S. Martel, et al., "Fundamental design rules for the conception of microdevices to be 
propelled in the blood circulatory system through magnetic gradients generated by a 
clinical MRI system," in Microtechnology in Medicine and Biology, 2005. 3rd 
IEEE/EMBS Special Topic Conference on, 2005, pp. 253-256. 
[40] A. Jordan, et al., "Magnetic fluid hyperthermia (MFH)," in Proceedings of an 
international conference on Scientific and Clinical Applications of Magnetic Carriers, U. 
Hafeli, et al., Eds., ed. Rostock, Germany: Plenum Press, New York, 1997. 
[41] O. V. Melnikov, et al., "Ag-doped manganite nanoparticles: New materials for 
temperature-controlled medical hyperthermia," Journal of Biomedical Materials Research 
Part A, vol. 91A, pp. 1048-1055, 2009. 
[42] F. Bertsch, et al., "Non-invasive temperature mapping using MRI: comparison of two 
methods based on chemical shift and T1-relaxation," Magnetic Resonance Imaging, vol. 
16, pp. 393-403, 1998. 
[43] T. Pradell, et al., "Technology of Islamic lustre," Journal of Cultural Heritage, vol. 9, pp. 
e123-e128, 2008. 
[44] M. C. Roco, "Nanotechnology: convergence with modern biology and medicine," Current 
Opinion in Biotechnology, vol. 14, pp. 337-346, 2003. 
[45] M. Corti, et al., "Magnetic properties of novel superparamagnetic MRI contrast agents 
based on colloidal nanocrystals," Journal of Magnetism and Magnetic Materials, vol. 
320, pp. e320-e323, 2008. 
[46] E. S. Kawasaki and A. Player, "Nanotechnology, nanomedicine, and the development of 
new, effective therapies for cancer," Nanomedicine: Nanotechnology, Biology and 
Medicine, vol. 1, pp. 101-109, 2005. 
[47] S. K. Sahoo, et al., "The present and future of nanotechnology in human health care," 
Nanomedicine: Nanotechnology, Biology and Medicine, vol. 3, pp. 20-31, 2007. 
[48] L. T. Terry B Huff, Yan Zhao, Matthew N Hansen, Ji-Xin Cheng, Alexander Wei, 
"Hyperthermic effects of gold nanorods on tumor cells," nanomedicine, vol. 2 (1), pp. 
125-132, 2007. 
  85 
 
[49] A. Wijaya, et al., "Magnetic field heating study of Fe-doped Au nanoparticles," Journal 
of Magnetism and Magnetic Materials, vol. 309, pp. 15-19, 2007. 
[50] D. P. O'Neal, et al., "Photo-thermal tumor ablation in mice using near infrared-absorbing 
nanoparticles," Cancer Letters, vol. 209, pp. 171-176, 2004. 
[51] S. N. Kale, et al., "Cerium doping and stoichiometry control for biomedical use of 
La0.7Sr0.3MnO3 nanoparticles: microwave absorption and cytotoxicity study," 
Nanomedicine: Nanotechnology, Biology and Medicine, vol. 2, pp. 217-221, 2006. 
[52] W. H. Suh, et al., "Nanotechnology, nanotoxicology, and neuroscience," Progress in 
Neurobiology, vol. 87, pp. 133-170, 2009. 
[53] Gilchrist R. K., et al., "Selective Inductive Heating of Lymph Nodes," Annals of Surgery, 
vol. 146, pp. 596-606, 1957. 
[54] M. Zeisberger, et al., "Metallic cobalt nanoparticles for heating applications," Journal of 
Magnetism and Magnetic Materials, vol. 311, pp. 224-227, 2007. 
[55] D.-H. Kim, et al., "Heat generation of aqueously dispersed CoFe2O4 nanoparticles as 
heating agents for magnetically activated drug delivery and hyperthermia," Journal of 
Magnetism and Magnetic Materials, vol. 320, pp. 2390-2396, 2008. 
[56] J. Chatterjee, et al., "Synthesis and characterization of polymer encapsulated Cu-Ni 
magnetic nanoparticles for hyperthermia applications," Journal of Magnetism and 
Magnetic Materials, vol. 293, pp. 303-309, 2005. 
[57] T. N. Brusentsova, et al., "Synthesis and investigation of magnetic properties of Gd-
substituted Mn-Zn ferrite nanoparticles as a potential low-TC agent for magnetic fluid 
hyperthermia," Journal of Magnetism and Magnetic Materials, vol. 293, pp. 298-302, 
2005. 
[58] Q.-s. Tang, et al., "Using thermal energy produced by irradiation of Mn-Zn ferrite 
magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression," Biomaterials, 
vol. 29, pp. 2673-2679, 2008. 
[59] B. D. Cullity and C. D. Graham, Introduction to magnetic materials. New York: Addison-
Wesley, 1972. 
[60] L. A. Harris, "Polymer Stabilized Magnetite Nanoparticles and Poly(propylene oxide) 
Modified Styrene-Dimethacrylate Networks," DOCTOR of PHILOSOPHY, 
CHEMISTRY, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, 
2002. 
[61] D. Jiles, Introduction to magnetism and magnetic materials, 1st ed. New York: Chapman 
and Hall, 1990. 
[62] E. Duguet, et al., "Towards a versatile platform based on magnetic nanoparticles for in 
vivo applications," Bulletin of Materials Science, vol. 29, pp. 581-6, 2006. 
[63] C.-R. Lin, et al., "Magnetic properties of monodisperse iron oxide nanoparticles," in 50th 
Annual Conference on Magnetism and Magnetic Materials, San Jose, California (USA), 
2006, pp. 08N710-3. 
  86 
 
[64] E. C. Stoner and E. P. Wohlfarth, "A mechanism of magnetic hysteresis in heterogeneous 
alloys," Magnetics, IEEE Transactions on, vol. 27, pp. 3475-3518, 1991. 
[65] Mi Kyong Yoo, et al., "Superparamagnetic Iron Oxide Nanoparticles Coated with 
Galactose-Carrying Polymer for Hepatocyte Targeting," Journal of Biomedicine and 
Biotechnology, vol. 2007, April 2007 2007. 
[66] Brown and W. Fuller, "Thermal Fluctuations of a Single-Domain Particle," Physical 
Review, vol. 130, p. 1677, 1963. 
[67] W. F. Brown, "Thermal Fluctuations of a Single-Domain Particle," Physical Review, vol. 
130, p. 1677, 1963. 
[68] D. Weller and A. Moser, "Thermal effect limits in ultrahigh density magnetic recording," 
IEEE Transactions on Magnetics, vol. 35, pp. 4423-4439, November 1999. 
[69] B. Fischer, et al., "Brownian relaxation of magnetic colloids," Journal of Magnetism and 
Magnetic Materials, vol. 289, pp. 74-77, 2005. 
[70] R. E. Rosensweig, "Heating magnetic fluid with alternating magnetic field," Journal of 
Magnetism and Magnetic Materials, vol. 252, pp. 370-374, 2002. 
[71] L. v. Michael and et al., "Magnetically induced hyperthermia: size-dependent heating 
power of Î³-Fe 2 O 3 nanoparticles," Journal of Physics: Condensed Matter, vol. 20, p. 
204133, 2008. 
[72] J. A. Stratton, Electromagnetic Theory. New York: McGraw-Hill, 1941. 
[73] T. A. Moore and J. A. C. Bland, "Mesofrequency dynamic hysteresis in thin 
ferromagnetic films," Journal of Physics: Condensed Matter, vol. 16, p. R1369, 2004. 
[74] M. Suto, et al., "Heat diffusion characteristics of magnetite nanoparticles dispersed hydro-
gel in alternating magnetic field," Journal of Magnetism and Magnetic Materials, vol. 
321, pp. 3483-3487, 2009. 
[75] C. A. Sawyer, et al., "Modeling of temperature profile during magnetic thermotherapy for 
cancer treatment," Journal of Applied Physics, vol. 105, pp. 07B320-07B320-3, 2009. 
[76] R. Hergt, et al., "Physical limits of hyperthermia using magnetite fine particles," 
Magnetics, IEEE Transactions on, vol. 34, pp. 3745-3754, 1998. 
[77] W. Andra, et al., "Temperature distribution as function of time around a small spherical 
heat source of local magnetic hyperthermia," Journal of Magnetism and Magnetic 
Materials, vol. 194, pp. 197-203, 1999. 
[78] E. P. Charles Polk, Handbook of Biological Effects of Electromagnetic Fields, 2nd ed.: 
CRC, December 21, 1995. 
[79] L.-Y. Zhang, et al., "Magnetite ferrofluid with high specific absorption rate for 
application in hyperthermia," Journal of Magnetism and Magnetic Materials, vol. 311, 
pp. 228-233, 2007. 
[80] ICNIRP, "Guidelines for limiting exposure to time-varying electric, magnetic, and 
electromagnetic fields (up to 300 gHz)," Health Physics, vol. 74, pp. 494-522, April 1998 
1998. 
  87 
 
[81] Q. A. Pankhurst, et al., "Applications of magnetic nanoparticles in biomedicine," Journal 
of Physics D: Applied Physics, vol. 36, pp. R167-R181, 2003. 
[82] K. Okawa, et al., "Heating ability of magnetite nanobeads with various sizes for magnetic 
hyperthermia at 120 kHz, a noninvasive frequency," Journal of Applied Physics, vol. 99, 
p. 08H102, 2006. 
[83] M. Johannsen, et al., "Clinical hyperthermia of prostate cancer using magnetic 
nanoparticles: Presentation of a new interstitial technique," International Journal of 
Hyperthermia, vol. 21, pp. 637 - 647, 2005. 
[84] R. Hergt and S. Dutz, "Magnetic particle hyperthermia--biophysical limitations of a 
visionary tumour therapy," Journal of Magnetism and Magnetic Materials, vol. 311, pp. 
187-192, 2007. 
[85] C. N. Marin, et al., "The dependence of the effective anisotropy constant on particle 
concentration within ferrofluids, measured by magnetic resonance," Journal of Physics D: 
Applied Physics, vol. 34, pp. 1466-1469, 2001. 
[86] A. Jordan, et al., "Inductive heating of ferrimagnetic particles and magnetic fluids: 
Physical evaluation of their potential for hyperthermia," International Journal of 
Hyperthermia, vol. 9, pp. 51 - 68, 1993. 
[87] W. J. Atkinson, et al., "Usable Frequencies in Hyperthermia with Thermal Seeds," IEEE 
Transactions on Biomedical Engineering, vol. BME-31, pp. 70-75, 1984. 
[88] S. Dutz, et al., "Hysteresis losses of magnetic nanoparticle powders in the single domain 
size range," Journal of Magnetism and Magnetic Materials, vol. 308, pp. 305-312, 2007. 
[89] R. A. J. Freitas, Nanomedicine vol. Basic Capabilities. Georgetown, TX: Landes 
Bioscience, 1999. 
[90] M. Polson, et al., "Stimulation of nerve trunks with time-varying magnetic fields," 
Medical and Biological Engineering and Computing, vol. 20, pp. 243-244, 1982. 
[91] K. S. CS Satish, HG Shivakumar, "Hydrogels as controlled drug delivery systems: 
Synthesis, crosslinking, water and drug transport mechanism," Indian J Pharm Sci, vol. 
68, pp. 133-140, 2006. 
[92] E. S. Gil and S. M. Hudson, "Stimuli-reponsive polymers and their bioconjugates," 
Progress in Polymer Science, vol. 29, pp. 1173-1222, 2004. 
[93] S. Martel, et al., "Automatic navigation of an untethered device in the artery of a living 
animal using a conventional clinical magnetic resonance imaging system," Applied 
Physics Letters, vol. 90, p. 114105, 2007. 
[94] Tabatabaei N., et al., "Magnetic nanoparticles encapsulated in hydrogel as hyperthermic 
actuators for microrobots designed to operate in the vascular network," presented at the 
The 2009 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS), 
St. Louis, USA, Oct 11-15 2009. 
 
 
  88 
 
 
APPENDIX – MATLAB® SIMULATION CODES 
A.1  Figure 2.8: Relaxation time vs. Particle size for MNP 
u_0=pi*4e-7;                         % volts.second/amp/meter   
Anisotropy = 2.64e4;                 %J m^-3 for magnetite 
Temperature = 297;                   %Kelvin room temperature 
Viscosity=1e-3;                      %Pa.s (kg/m/s);                   
t_0=1e-9; 
k=1.38e-23;                          % J/K (Boltzman Constant)(J=w.s)  
Density = 5.18;                      %g/cm^3 for Magnetite 
Ms_VSM =60;                          %emu/g  
Ms = Ms_VSM * Density * 1e3;         %A/m 
Coating = 40e-9;                     %meter 
Radius = 5e-9:1e-9:10e-9;            %nm 
  
for r=1:length(Radius) 
  
volume(r) = Volume(Radius(r)); 
  
%%% t_Neel  
  
GAMMA(r) = Anisotropy * volume(r) / k / Temperature; 
  
t_Neel(r) = (sqrt(pi) / 2) * t_0 * exp(GAMMA(r))/((GAMMA(r))^(1/2)); 
  
%%%% Brownian relaxation 
  
volume_hydro(r) = volume(r) * (1 + Coating/Radius(r))^3 ; 
  
t_Brownian(r) = 3 * Viscosity * volume_hydro(r)/k/Temperature; 
  
%%% t_effect 
  
t_effect(r) = t_Neel(r) * t_Brownian(r) /(t_Neel(r) + t_Brownian(r)); 
  
end 
  
semilogy (Radius, t_Brownian,'r','Linewidth',3) 
hold on 
semilogy (Radius, t_Neel,'b','Linewidth',3) 
hold on 
semilogy (Radius, t_effect,'g','Linewidth',3) 
  
title('Relaxation time vs. Particle size for MNP', 'FontSize',15) 
ylabel('\tau(s)','FontSize',15); 
xlabel('Particle Radius (m)','FontSize',15); 
text(8.6e-9, 1, '\tau_N_e_e_l', 'FontSize',15) 
text(5.5e-9, 1e-4, '\tau_B_r_o_w_n_i_a_n', 'FontSize',15) 
text(9e-9, 9e-5, '\tau_e_f_f_e_c_t', 'FontSize',15) 
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set(gca,'FontSize',14); 
grid on 
A.2  Figure 2.11: Susceptibility components vs. Frequency 
%%% Stoner-Wohlfarth Losses for small particles 
  
u_0=pi*4e-7;                        % volts.second/amp/meter   
  
Aisotropy = 2.64e4;                 %J m^-3 for magnetite 
Temperature = 297;                  %Kelvin room temperature 
Viscosity=1e-3;                     %Pa.s (kg/m/s) for ferrofluids 
volume_fraction=0.071;              %volume fraction solid 
Density = 5.18;                     %g/cm^3 for Magnetite 
Ms_VSM =60;                         %emu/g  
Ms = Ms_VSM * Density * 1e3         %A/m 
Radius = 6e-9;                      %meter         
Md = Ms / volume_fraction 
  
volume = Volume(Radius); 
Field = 10e3;                       %A/m 
Coating = 40e-9;                    %meter 
frequency = 0:1e5:1e7;              %Hz 
  
  
%Hydrodynamic diameter = shell thickness + core diameter + shell thickness = 
20 nm + 10 nm + 20 nm = 50 nm 
  
  
t_Neel = t_Neel(u_0, Anisotropy, Ms,volume,Temperature) 
t_Brownian = t_Brownian(Viscosity, volume, Radius, Temperature, Coating) 
t_effect = t_effect(t_Neel, t_Brownian); 
  
for f=1:length(frequency) 
    
Phi(f) = t_effect * 2 * pi * frequency(f);           %dimentionless  
Initial_Susc = Initial_Susceptibility (Ms,volume,volume_fraction, 
Temperature);        %dimensionless 
DC_Susc = DC_Susceptibility (Initial_Susc, Field, volume_fraction, Ms , 
volume,Temperature); 
Susc(f) = Susceptibility (DC_Susc,Phi(f)); 
sus_real(f) = DC_Susc / (1+(Phi(f))^2); 
sus_img(f) = Phi(f)* DC_Susc / (1+(Phi(f))^2); 
 
end 
 
semilogx (frequency, sus_img/DC_Susc,'r','Linewidth',3) 
hold on 
semilogx (frequency, real(sus_real/DC_Susc),'b','Linewidth',3) 
title('Susceptibility components vs. Frequency', 'FontSize',15) 
ylabel('\chi/\chi_0','FontSize',15); 
xlabel('Frequency (Hz)','FontSize',15); 
text(7e5, 0.4, '\chi_i_m_a_g_i_n_a_r_y', 'FontSize',15) 
text(8e5, 0.8, '\chi_r_e_a_l', 'FontSize',15) 
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set(gca,'FontSize',14); 
grid on; 
 
A.3   Figure 2.13: Time dependent temperature increase as a 
function of distance 
%%% Theoretical Estimation for Temperature distribution 
 
% r1 must be >= to t1 
  
clear all 
close all 
  
R = 3e-3;                             % meter radius of the spherical volume 
P = 6.57*1e6;                         % W/m^3 power 
  
lamda1 = 0.778;                       % W/(K m) heat conductivity medium 1 
lamda2 = 0.642;                       % W/(K m) heat conductivity medium 2 
q_lamda = lamda2/lamda1; 
  
rho1 = 1.66e6;                        % g/m^3 density medium 1 
rho2 = 1e6;                           % g/m^3 density medium 2 
  
c1 = 2.54;                            % J/(g K) heat capacity medium 1 
c2 = 3.72;                            % J/(g K) heat capacity medium 2 
q = (rho2*c2)/(rho1*c1); 
  
%% detla T1 
  
delta_T1={}; 
  
index1 = 1; 
vec1 = []; 
for t=[30, 60, 120, 300, 3600]; 
  
    for r1=1e-4:1e-4:R; 
         
f = @(z) (z^(-2))*exp(((-lamda1)*t*z^2)/(rho1*c1*R^2))*((z*cos(z))-sin(z))/((( 
((q_lamda-1)*sin(z))+ (z*cos(z)) )^2)+q_lamda*q*(z*sin(z))^2); 
g1 = @(z) sin(r1*z/R); 
fXg1=@(z) f(z)*g1(z); 
fg1=@(z) arrayfun(fXg1,z); 
intfg1 = quad(fg1,0,10); 
delta_T1{index1} = (P * R^2 / 3 / lamda2)*(1 + ((q_lamda / 2) *( 1 - r1^ 2 / 
R^ 2))  + ( 6 /pi)*q_lamda^(3/2)*q^(1/2)*(R/r1)*intfg1); 
         
        index1 = index1 +1; 
    end 
     
    for i=1:index1-1 
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        vec1 = [vec1 delta_T1{i}]; 
    end 
    index1 = 1; 
end 
  
r1=1e-1:1e-1:3;    
  
plot(r1,vec1(1:30),'Linewidth',2) 
hold on; 
  
plot(r1,vec1(31:60),'Linewidth',2) 
hold on; 
  
plot(r1,vec1(61:90),'Linewidth',2) 
hold on; 
  
plot(r1,vec1(91:120),'Linewidth',2) 
hold on; 
  
plot(r1,vec1(121:150),'Linewidth',2) 
hold on; 
  
%% delta T2 
  
delta_T2={}; 
  
index2 = 1; 
vec2 = []; 
for t=[30, 60, 120, 300, 3600] 
  
    for r2=R:1e-4:15e-3; 
         
f = @(z) (z^(-2))*exp(((-lamda1)*t*z^2)/(rho1*c1*R^2))*((z*cos(z))-sin(z))/((( 
((q_lamda-1)*sin(z))+ (z*cos(z)) )^2)+q_lamda*q*(z*sin(z))^2); 
g2 = @(z) ((((q_lamda-1)*sin(z))+ (z*cos(z)))*sin((q/q_lamda)^(1/2)*z*((r2/R)-
1)))+((q_lamda*q)^(1/2)*z*sin(z)*cos((q/q_lamda)^(1/2)*z*((r2/R)-1))); 
fXg2=@(z) f(z)*g2(z)/z; 
fg2=@(z) arrayfun(fXg2,z); 
intfg2 = quad(fg2,0,10); 
delta_T2{index2} = (P * R^3 / 3 / lamda2/r2)*(1 + ((6*q_lamda / pi)*intfg2)); 
         
        index2 = index2 +1; 
    end 
    for i=1:index2-1 
        vec2 = [vec2 delta_T2{i}]; 
    end 
    index2 = 1; 
end 
  
r2=3:1e-1:15;         
  
plot(r2,vec2(1:121),'Linewidth',2) 
hold on; 
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plot(r2,vec2(122:242),'Linewidth',2) 
hold on; 
  
plot(r2,vec2(243:363),'Linewidth',2) 
hold on; 
  
plot(r2,vec2(364:484),'Linewidth',2) 
hold on; 
  
plot(r2,vec2(485:605),'Linewidth',2)  
ylabel('\DeltaT (K)','FontSize',15); 
xlabel('r (mm)','FontSize',15); 
title('Temperature increase as function of distance','FontSize',14); 
text(3,30.7,'----------------------- 3600 s','FontSize',14);     
text(3.1,22.62,'---------------------- 3000 s','FontSize',14);  
text(3.1,18.82,'---------------------- 120 s','FontSize',14); 
text(3.1,15.07,'---------------------- 60 s','FontSize',14);     
text(3.2,10,'---------------------- 30 s','FontSize',14); 
set(gca,'FontSize',14); 
grid on; 
 
A.4   Figure 2.15: Power loss due to Neel relaxation vs. radius of 
MNP 
%%%%%%%%%%%%%%%%%%%%%%%% 
%%% Grain size dependence  
%%% of the loss power denisty  
%%% due to Neel-relaxation 
%%% for small magnetite 
%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
  
%%% SAR_Neel = (u0 f pi x0 (H)^2 2pi f t / [rho (1+(wt)^2)] 
%%% w = Angular_Freq 
%%% t = t_Neel 
  
  
clc 
clear all 
  
  
k=1.38e-23;                             % J/K (Boltzman Constant)(J=w.s)   
K=1.18e4;                               % Shape anisotropy Fe3O4 J/m^3 aspect 
ratio of 1.4 
u_0=pi*4e-7;                            % volts.second/amp/meter   
Temperature = 273+37;                   % Kelvin (Body temperature) 
volume_fraction=0.071;                  % volume fraction solid 
Density = 5.18;                         % g/cm^3 
H_field = 82.0;                         % Oe = 6.5 kA/m 
Magnetization = 40;                     % @ H = 82 Oe, (emu /g)                                        
Ms_emu_g = 90;                          % Magnetization saturation (emu/g) 
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Ms = Ms_emu_g * Density * 1e3;          % A/m 
t_0 = 1e-10; 
Radius = 7e-9:1e-10:12e-9;              % meter 
Frequency = [2e4,2e5,2e6];              % Hz 
  
for i=1:length(Radius) 
     
     
    Volume(i)=4/3 * pi * (Radius(i))^3;                          % m^3 
    t_Neel(i) = t_0 * exp(K * Volume(i)/k/Temperature);          % second 
     
    %domain magnetization of a suspended particle 
    Md = Ms / volume_fraction;                
  
    %from Langevin relationship: 
    Initial_Susc(i) = u_0 * volume_fraction * (Md^2) * volume(i) / 3 / k / 
Temperature; 
  
    xi(i) =  u_0* Md * H_field * volume(i) / k / Temperature; %dimensionless 
    DC_Susc(i) = Initial_Susc(i) * 3 * (coth (xi(i)) - (1/xi(i))) / xi(i); 
     
    for f=1:length(Frequency) 
         
        Angular_Freq(f) = 2 * pi * Frequency(f);      % radian 
         
        A=u_0*Frequency(f)*H_field^2*pi*DC_Susc(i)*Angular_Freq(f)*t_Neel(i); 
         
        B=1+(Angular_Freq(f)*t_Neel(i))^2; 
         
        SAR(i,f)=A/B/Density/1e6; 
         
    end 
     
end 
     
semilogy (Radius,SAR,'Linewidth',1.5); 
ylabel('SAR (W/g)','FontSize',15); 
xlabel('Radius (m)','FontSize',15); 
text(6.5e-9,3e1,'f = 2x10^6 Hz \rightarrow','FontSize',14); 
text(7.6e-9,3,'f = 2x10^5 Hz \rightarrow','FontSize',14);     
text(8.2e-9,0.2,'f = 2x10^4 Hz \rightarrow','FontSize',14);  
set(gca,'FontSize',14); 
%print -djpeg -r300 SARvsParticle_Jpeg_REVISED!!! 
 
A.5    Figure 2.16: Biological limitation to field and frequency 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
% this will calculate the amount of 
% SAR that is absorbed by body tissue 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% 
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u0 = pi*4e-7;           % permeability of vacuum (H/m) 
u  = 100*u0;            % permeability of  (H/m) 
Conductivity = 0.6;     % tissue conductivity (ohm^-1 m^-1) 
Radius = 10;            % radius of the region EMF is applied on (cm) 
  
density=0.8;            %average tissue density (g/cm^3) 
  
%limitation set by 'Usable Frequencies for Hyperthemria with Thermal 
%Seeds' --> 13.56 MHz at 35.8 A/m  for extended time --> 25 mW/ml 
 
Limit = 0.025;          %SAR (W/ml) or (W/cm^3) 
                        %Ref: Usable Frequencies in Hyperthermia with 
                        %Thermal Seeds: limit H0f <=  4.85x10^8 A/m/s 
% The resulting SAR value is 
% unlikely to produce a localized temperature increment of 
% more than 1°C in the limbs (Chatterjee et al. 1986; Chen 
% and Gandhi 1988; Hoque and Gandhi 1988), which has 
% been suggested as the upper limit of temperature increase 
% that has no detrimental health effects (UNEP/WHO/ 
% IRPA 1993). 
% In general, these have 
% demonstrated that exposure for up to 30 min, under 
% conditions in which whole-body SAR was less than 
% 4 W/kg, caused an increase in the body core temperature 
% of less than 1°C. 
  
% Summary of biological effects and epidemiological 
% studies (100 kHz–300 GHz) 
  
% Available experimental evidence indicates that the 
% exposure of resting humans for approximately 30 min to 
% EMF producing a whole-body SAR of between 
% 1 and 4 W/kg results in a body temperature increase of 
% less than 1 °C. Animal data indicate a threshold for 
% behavioral responses in the same SAR range. Exposure 
% to more intense fields, producing SAR values in excess 
% of 4 W/kg, can overwhelm the thermoregulatory 
% capacity of the body and produce harmful levels of tissue 
% heating. Many laboratory studies with rodent and nonhuman 
% primate models have demonstrated the broad 
% range of tissue damage resulting from either partial-body 
% or whole-body heating producing temperature rises in 
% excess of 1–2°C. The sensitivity of various types of 
% tissue to thermal damage varies widely, but the threshold 
% for irreversible effects in even the most sensitive tissues 
% is greater than 4 W/kg under normal environmental 
% conditions. These data form the basis for an occupational 
% exposure restriction of 0.4 W/kg, which provides a 
% large margin of safety for other limiting conditions such 
% as high ambient temperature, humidity, or level of 
% physical activity. 
 
%initializing vectors of frequency and field amplitude 
freq=[]; 
field=[]; 
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H_field=1e3:1e2:10e3;        %initial to final field (A/m) 
  
for i=1:length(H_field) 
  
    A=0;                  %initial to final (Hz) 
    B=1e6; 
    Frequency=A:1e4:B;         
     
    
    for ii=1:length(Frequency) 
  
              
       w(ii) = 2*pi*Frequency(ii);      %angular frequency 
        
       %W/cm^3 
       P_N(i,ii) =  1e-
6*(w(ii)^2)*(u0^2)*(Conductivity/8)*(H_field(i))^2*(Radius*1e-2)^2; 
        
       %W/g 
       P_N_2(i,ii)=P_N(i,ii)/density; 
        
         if P_N(i,ii) <= Limit && P_N(i,ii) >= (Limit-1e-3) 
             
           freq = [freq; Frequency(ii)]; 
           field = [field; H_field(i)]; 
  
           
         end     
        
    end 
        
end 
  
plot (freq,field,'LineWidth',2); 
grid on; 
xlabel('Frequency (Hz)','FontSize',15); 
ylabel('Field (A/m)','FontSize',15); 
title(['Field vs. Frequency for Loss Power limit of ',num2str(Limit*1000),' 
mW/ml'],'FontSize',15) 
text(2e5,8000,'Radius of the applied AC magnetic field = 10 
cm','FontSize',14); 
text(1.6e5,4800,'\leftarrow f = 160 kHz ','FontSize',14); 
text(1.9e5,4200,'H = 4.5 kA/m','FontSize',14); 
set(gca,'FontSize',14); 
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A.6       Figure 5.3: Time dependent temperature increase as function 
of distance 
%%% Theoretical Estimation for Temperature distribution as a function of time 
%%% and distancve 
clc  
clear all 
  
%% Welcome 
  
% r1 must be >= to t1 
  
close all 
  
%% 
  
R_carrier= (50e-6)/2; 
R_tumour=(30e-3)/2; 
  
Number_carrier=110000; 
  
V_carrier=4/3*pi*(R_carrier)^3; 
V_tumour=4/3*pi*(R_tumour)^3; 
V_Total_carrier=Number_carrier*V_carrier; 
  
Percent_tumour_carrier=V_Total_carrier/V_tumour*100; 
fprintf(' %0.3f Percent Carrier in Tumour',Percent_tumour_carrier); 
  
  
  
percentage_Fe3O4=0.4;                   % 40% magnetite in each micro-carrier 
  
V_Total_Fe3O4=percentage_Fe3O4*V_Total_carrier; 
  
Density= 5.15e6;                        % g/m^3 
  
gramParticle=Density*V_Total_Fe3O4;     % gram 
  
SAR=61.02;                              % W/g 
  
Concentration=gramParticle*1000/(V_tumour*1e6);  %mg/ml 
fprintf('\n Concentration: %0.3f mg magnetite/ml Tumour',Concentration) 
  
R = R_tumour;                           % meter radius of the spherical volume 
P = SAR*gramParticle/V_tumour;          % W/m^3 power 
  
lamda1 =0.778;                          % W/(K m) heat conductivity magnetite 
ferrofluid (ref: Simulation of heat transfer in a ferrofluid using 
computational fluid dynamics technique) 
lamda2 = 0.642;                         % W/(K m) heat conductivity styrofoam 
q_lamda = lamda2/lamda1; 
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rho1 = 5.15e6;                          % g/m^3 density magnetite 
rho2 = 1e6;                             % tissue g/m^3 density  
  
c1 = 2.54;                              % J/(g K) heat capacity magnetite  
c2 = 3.72;                              % J/(g K) heat capacity tissue 
  
q = (rho2*c2)/(rho1*c1); 
  
%% detla T1 
  
delta_T1={}; 
  
index1 = 1; 
vec1 = []; 
for t=[700,1500]; 
  
    for r1=1e-4:1e-4:R; 
         
        f = @(z) (z^(-2))*exp(((-lamda1)*t*z^2)/(rho1*c1*R^2))*((z*cos(z))-
sin(z))/((( ((q_lamda-1)*sin(z))+ (z*cos(z)) )^2)+q_lamda*q*(z*sin(z))^2); 
        g1 = @(z) sin(r1*z/R); 
        fXg1=@(z) f(z)*g1(z); 
        fg1=@(z) arrayfun(fXg1,z); 
        intfg1 = quad(fg1,0,10); 
        delta_T1{index1} = (P * R^2 / 3 / lamda2)*(1 + ((q_lamda / 2) *( 1 - 
r1^ 2 / R^ 2))  + ( 6 /pi)*q_lamda^(3/2)*q^(1/2)*(R/r1)*intfg1); 
         
        index1 = index1 +1; 
    end 
     
    
    for i=1:index1-1 
        vec1 = [vec1 delta_T1{i}]; 
    end 
    index1 = 1; 
end 
  
r1=1e-1:1e-1:15;   %150 
  
plot(r1,vec1(1:150),'Linewidth',2) 
hold on; 
  
plot(r1,vec1(151:300),'Linewidth',2) 
hold on; 
  
%% delta T2 
  
delta_T2={}; 
  
index2 = 1; 
vec2 = []; 
for t=[700, 1500] 
  98 
 
  
    for r2=R:1e-4:50e-3; 
         
        f = @(z) (z^(-2))*exp(((-lamda1)*t*z^2)/(rho1*c1*R^2))*((z*cos(z))-
sin(z))/((( ((q_lamda-1)*sin(z))+ (z*cos(z)) )^2)+q_lamda*q*(z*sin(z))^2); 
        g2 = @(z) ((((q_lamda-1)*sin(z))+ 
(z*cos(z)))*sin((q/q_lamda)^(1/2)*z*((r2/R)-
1)))+((q_lamda*q)^(1/2)*z*sin(z)*cos((q/q_lamda)^(1/2)*z*((r2/R)-1))); 
        fXg2=@(z) f(z)*g2(z)/z; 
        fg2=@(z) arrayfun(fXg2,z); 
        intfg2 = quad(fg2,0,10); 
        delta_T2{index2} = (P * R^3 / 3 / lamda2/r2)*(1 + ((6*q_lamda / 
pi)*intfg2)); 
         
        index2 = index2 +1; 
    end 
     
    
    for i=1:index2-1 
        vec2 = [vec2 delta_T2{i}]; 
    end 
    index2 = 1; 
end 
  
r2=15:1e-1:50;        %351 
  
plot(r2,vec2(1:351),'Linewidth',2) 
hold on; 
plot(r2,vec2(352:702),'Linewidth',2) 
hold on; 
  
ylabel('\DeltaT (K)','FontSize',15); 
xlabel('Radius (mm)','FontSize',15); 
  
text(22,4.5,'SAR = 61.02 W/g','FontSize',14);     
text(22,4.1,'No. of micro-carriers = 110,000','FontSize',14);    
text(22,3.7,'1.049 mg magnetite / ml Tumour','FontSize',14);    
text(16,2.5,'---------------------- 1500 seconds','FontSize',14);  
text(16,1.5,'---------------------- 700 seconds','FontSize',14); 
  
set(gca,'FontSize',14); 
%grid on; 
%print -djpeg -r300 SAR61Time1500No1100000 
  
 
 
